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ABSTRACT
Objectives:
The purpose of this study is to determine whether selective immunohistochemical markers may 
aid in the differential diagnosis of morphologically difficult salivary gland tumors.
Study Design:
The  records  and  archival  paraffin  blocks  of  the  Department  of  Oral  Pathology  and 
Microbiology, Tamil Nadu Government Dental College and Hospital, Chennai, South India, served as a 
source of material for this study. About 20 salivary gland tumors [PA (7), PLGAs (3), ACC (4), BAC 
(1), SDC (1), Clear cell salivary gland tumors (2) and unusual adenocarcinomas (2)] were selected 
from the record for the study. Formalin-fixed and paraffin embedded tissue sections of the tumors were 
immunohistochemically analyzed for the presence of  SMA, CK, GFAP, c-kit, vimentin and S-100 
protein  (only  in  few cases).  A  standard  streptovidin  peroxidase  procedure  was  used  after  antigen 
retrieval. To assure proper staining, salivary gland fragments, blood vessels and connective tissue fibers 
present  in  the  sections  adjacent  to  the  tumor  and within  the  tumor were used as  internal  positive 
controls.
Results:
PAs exhibited positivity to CK in 100% of cases, vimentin in 71% of cases, SMA in 57% of 
cases and c-kit in 71% of cases. PLGAs were positive to CK, vimentin and c-kit in 100% of cases and 
to SMA in 50% of cases. ACCs showed 
positivity to CK in 50% of cases, vimentin in 25% of cases, SMA in 75% of cases and c-kit in 100% of 
cases. GFAP staining was negative in all ACCs, PLGAs and 70% of PAs. BAC exhibited reactivity to 
all  markers  except  GFAP, whereas SDC was negative to  all  markers (CK, c-Kit,  GFAP, SMA & 
Vimentin). CCC demonstrated positivity in 100% of cases to CK and SMA (stroma only) and in 50% 
of cases to vimentin, while c-kit and S-100 were negative. Unusual adenocarcinomas were positive to 
CK and negative to GFAP in 100% of cases, whereas 50% of cases were positive in vimentin, c-kit and 
SMA. Out of the two unusual adenocarcinomas S-100 was used in only one case, where it was positive.
Conclusion:
This study suggests that the use of IHC as a supplemental diagnostic tool in border line or 
difficult salivary gland tumors may well augment the routine microscopic differential, especially when 
the pattern of reaction is taken into consideration.
Key words:
 Immunohistochemistry;  IHC; Salivary gland tumors; Pleomorphic adenoma; Adenoid cystic 
carcinoma;  Polymorphous  low-grade  adenocarcinoma;  Basal  cell  adenocarcinoma;  Salivary  duct 
carcinoma; Clear cell carcinoma; Canalicular adenoma; Basal cell adenoma; SMA, vimentin; S-100; 
GFAP; CK; c-kit.; Tamil Nadu Government Dental College; Chennai.
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INTRODUCTION
Salivary  gland  tumors  are  a  heterogenous  group  of  neoplasms  that  may 
manifest different cellular and growth phenotypes. The latest WHO classification lists 
40 named salivary gland tumors.1 These tumors range from the more frequent benign 
salivary tumor,  like PA, to more aggressive SDC or carcinoma ex PA. Therefore, 
distinction is an essential part of any diagnostic setup, which to the untrained or even 
for the experienced may pose considerable diagnostic challenge, especially with rare 
entities.  However,  most  of  the  salivary  gland  tumor  entities  can  reliably  be 
distinguished by recognition of cell types and specific growth patterns. Nonetheless, 
some  salivary  gland  tumors  manifest  overlapping  morphological  and  cellular 
phenotypes often making diagnosis difficult. 
The overlapping histological  features are commonly encountered in  tumors 
like PA, BA or PLGA, ACC and SDC. Thus, when a tumor does not fit within the 
established criteria for PLGA, ACC or MA (carcinoma) and mixed tumors with the 
use of routine stains, confirmation with IHC studies may be necessary or desirable. 
Although IHC have been regarded as confirmatory or supportive for the diagnosis of 
salivary gland tumors, no single marker would indicate a specific tumor type. Thus, 
IHC may often require  a  panel  of  immuno markers  that  are  costly to employ for 
routine diagnostic use. However, the use of CK, GFAP, c-kit and selective muscle 
markers such as SMA and vimentin can often be found helpful in delineating PA, CA, 
BAC, PLGA, ACC and SDC. For example, a weak reaction with PLGA but a strong 
reaction  with  ACC  by  SMA  may  help  in  the  distinction  of  these  two  entities. 
Similarly, a negative or weak reaction with GFAP can help to differentiate PLGA and 
ACC from CA or BAC and PA. 
Most  pathologists  often  employ  commercially  available  IHC  markers  to 
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discriminate potential salivary gland tumors but are not clear whether they provide 
unequivocal diagnostic clues in routine practice. The purpose of the present study is to 
determine whether the use of selective commercially available immunomarkers will 
provide  diagnostic  distinctions  in  borderline  or  difficult  cases  of  salivary  gland 
tumors.
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AIMS AND OBJECTIVES
1. The  aim  of  this  study is  to  identify  difficult  or  borderline  salivary  gland 
tumors from a review of 225 salivary gland tumors.
2. To determine whether selective commercially available immunohistochemical 
markers  may  aid  in  the  differential  diagnosis  of  morphologically  difficult 
salivary gland tumors.
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REVIEW OF LITERATURE
 Regezi et al in 19852 studied 17 PAs, 5 ACCs and a CA using the immuno 
markers  GFAP and S-100.  The  authors  have  found that  16 PAs were  positive  to 
GFAP whereas CA and 5 ACCs were negative to GFAP. In PAs, cells in myxoid and 
cartilage areas and plasmacytoid cells showed more intense reaction with GFAP than 
other areas.
Morinaga  et  al  in  19873 stated  that  the  normal  myoepithelial  cells  were 
positive for actin but negative for vimentin. Outer tubular cells of organoid double-
layered tubular  growth pattern which  were seen in  PA,  MA and ACC, the  ‘cyst’ 
-lining  cells  and  the  outermost  cells  of  cribriform  growth  pattern  in  ACC  were 
occasionally  positive  for  actin.  These  outer  tubular  cells,  ‘cyst’-lining  cells,  and 
outermost cells were considered to be neoplastic myoepithelial cells. However, their 
staining reaction was much lower than that  of normal myoepithelial  cells.  On the 
other hand, these neoplastic myoepithelial cells were always positive for vimentin. 
The ‘mesenchymal’cells and hyaline cells of PA (modified myoepithelial cells) and 
indifferent  cells  of  ACC  were  negative  for  actin,  but  positive  for  vimentin  and 
occasionally positive for keratin.
 Yamada et al in 19884 studied the expression of vimentin and keratin (KL1 7 
PKK1) in 80 cases of PA. The authors have found that 50 (63%) cases were positive 
with vimentin (20 strongly positive and 30 moderately positive), 5 cases were very 
slightly positive (6%) or gave trace staining and 25 cases were negative (31%) to 
vimentin.  Large  foci  with  squamous  metaplasia  showed  negativity  to  vimentin. 
Vimentin  was  expressed  with  variable  intensities  in  fibrous  stromal  elements  and 
peripheral/basal side of outer tumor cells (including some spindle cells) in the tubulo-
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ductal structures and with strong staining in modified or neoplastic myoepithelial cells 
and osteochondroidal cells.  The authors  also showed that  the keratin  staining was 
observed in the luminal tumor cells.
Stead et al in 19885 performed an IHC study of 34 PAs of the major salivary 
glands using GFAP, keratin, S-100 protein, CEA, EMA and SC. The authors have 
showed that PAs exhibited keratin staining in luminal cells of the ducts and intense 
GFAP  staining  in  periductal  and  stromal  cells  differentiating  epithelial  and 
myoepithelial  cells.  The  authors  have  suggested  that  the  presence  of  GFAP-like 
immunoreactivity  in  normal  myoepithelial  cells  strongly  supports  the  extensive 
involvement of these cells in PAs and the combination of keratin, S-100 and GFAP 
immunostaining is particularly useful in identifying the component cells in PAs of the 
salivary glands.
Mori et al in 19896 studied 41 cases of PA using the immuno markers keratin, 
vimentin and S-100. The authors have found that in PAs, great heterogeneity in the 
staining as well as multiple and co-expressions of these proteins were found in the 
outer tumor cells of tubulo-ductal structures and modified myoepithelial cells but not 
in  the  luminal  tumor  cells.  Among  the  outer  tumor  cells,  85% were  stained  for 
vimentin and 97% for K8.12 keratin. The authors also showed that the modified and 
neoplastic  myoepithelial  cells  showed similar  expressions  to  those of  outer  tumor 
cells.
Simpson et al in 19907 in their study CCC with AE1/AE3, S-100, GFAP, 
vimentin,  CAM  5.2,  HMFG  1&2,  CEA,  NSE,  thyroglobulin,  desmin,  actin  and 
myosin showed that staining was strongly positive with AE1, equivocal with AE3 and 
negative with S-100, GFAP and vimentin.
Simpson et al in 19918 studied the immunoreactivity of 6 cases of PLGA and 
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6 cases of ACC with immuno markers AE1/AE3, vimentin, keratin, S-100, CAM 5.2, 
HMFG 1, HMFG 2, and CEA. The authors have shown that all PLGAs showed some 
cytoplasmic staining for CK AE1 and to a lesser extent for vimentin whereas ACCs 
displayed diffuse cytoplasmic staining with CKs and negativity with vimentin. The 
authors have suggested that the microscopic differences were mainly cytological and 
to  a  lesser  extent  morphological  and  the  IHC  reactions  of  two  tumors  were  not 
sufficiently dissimilar to be of practical value.
Regezi et al in 19919  studied the histopathological features and IHC staining of 16 cases of 
PLGA, 17 cases  of ACC and 21 other  histologically similar  minor salivary gland neoplasms with 
GFAP, vimentin, keratin (LMK & HMK), S-100 and MSA. The authors stated that the syncytium of 
tumor cells, often cribriform growth pattern was the H/P characteristic of PLGA. Small (single layered) 
ducts and fusiform spindle cells characterizing the peripheral aspects of the lesion and solid lobules 
with peripheral palisading enclosing central pseudoglandular structures were observed. In their study, 
mucous  cells  were  found in  3  cases,  clear  cells  in  one case  and  the  stroma ranged  from densely 
collagenous to hyalinized to mucoid.
In these, authors showed that the cribriform growth pattern in ACC appears as discrete islands 
(in contrast to the cellular syncytium seen in PLGAs) and are surrounded by retraction spaces or clefts. 
In their study, cribriform growth pattern was present in all ACCs and was the dominant histologic 
feature in 14/17 cases, whereas tubular or trabecular pattern was found in only 3 cases. They also found 
that PLGA showed a single layer in the ducts compared to characteristic bilayered ducts in ACC.  The 
authors have shown that among a total of 16 PLGAs and 17 ACCs, 1 PLGA and 2 ACCs showed focal 
or weak reaction with GFAP while vimentin and keratin expression were found in all tumors studied. 
In contrast, the MA in their series exhibited moderate immunostaining for GFAP (4 CAs & 3 BAs) and 
strong staining for keratin, whereas vimentin expression was found in the membranous variant.
 In this study, the authors have found that the IHC staining helped in the interpretation of 11 
tumors that were equivocal with H&E sections. It was shown that 3 PAs with PLGA features exhibited 
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moderate to strong staining for S-100, GFAP, vimentin and keratin. Of the 8 other equivocal tumors, 
staining patterns were similar to PLGA in 2 cases (strong S-100 and weak actin staining), ACC in 3 
cases  (weak  S-100 and moderate actin  staining) and  no distinctive pattern in  3  cases  which were 
labeled as adenocarcinoma (NOS).
 Nishimura et al in 199110 examined immunoreactivity of  60 cases of PA, 5 cases of BA and 
10 cases of ACC to keratin, vimentin, GFAP, actin, desmin, S-100 and SC. The authors showed that in 
cases  of  PA,  vimentin  immunoreactivity  was  present  in  almost  all  tumor  cells  of  epithelial  or 
mesenchymal differentiation, except for inner tubular cells and squamous epithelial cells. GFAP also 
showed the similar immunoreactivity but reactivity was significantly reduced in the mature chondroid 
cells with lacunar formation. They also showed that in both ACC and BA, vimentin was observed in 
some tumor cells but GFAP was consistently negative. The authors believe that GFAP may be useful in 
discrimination among the tumors they studied.
 Norberg et al in 199111 in their study of IHC of 3 cases of PLGA with CKs 
AE1/AE3, vimentin, EMA, CEA, MSA and S-100 found that all cases were positive 
for vimentin and staining was expressed in discrete region of basal cytoplasm in some 
tumor  cells  except  one  case  in  which  staining  was  infrequent.  The  authors  also 
showed that all 3 cases were positive to AE1/AE3 in luminal tumor cells forming duct 
like structures in the solid growth pattern in 2 cases and no specific pattern of tumor 
cell staining in one case. 
Ogawa et al in 199112 examined 3 cases of CCC with the immuno markers 
vimentin, S-100, GFAP, actin, keratin and EMA. The authors have found that case 1 
showed extensive positivity for vimentin and S-100 protein with focal expression of 
GFAP,  strongly  suggested  that  the  clear  cells  were  myoepithelial  in  nature.  In 
contrast, the clear cells from case 2 and 3 expressed keratin.
Jones et al in 199213 compared the immunoreactivity of α-SMA and S-100 
protein in a wide range of salivary gland tumors. The authors selected 6 PLGAs, 3 
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ACCs, 10 PAs and 4 SDCs for their study and have found that among 6 PLGAs, 5 
displayed some staining with α-SMA, but this was much less pronounced than the 
S-100 in 3 cases consisting of just isolated cells and 2 tumors expressed α-SMA in 
outer  cell  layer.   Two  out  of  three  ACCs  showed  focal  weak  α-SMA 
immunoreactivity. They also found that in 10 PAs, the inner duct lining cells were 
negative  for  α-SMA,  but  focal  weak  positivity  was  noted  in  some  tubules  in  an 
apparent myoepithelial cell layer and only occasional cells in the matrix expressed α-
SMA. All SDCs were negative to α-SMA.        
 Delgado et al in 199314 studied 14 cases of SDC using the immuno markers 
SMA, CEA, BRST, CKs (HMK & LMK), S-100, MSA and LeuM-1. The authors 
indicated that SDC was composed entirely of ductal cells without the participation of 
myoepithelial cells as the battery of myoepithelial markers (SMA & MSA) failed to 
stain neoplastic cells.
Williams et al in 199315 analysed 23 cases of BAC and 11 cases of BA using 
the immuno markers CK, GFAP, SMA, vimentin, S-100, CEA, EMA, B72.3, Ber-
EP4 and HMFG. The authors have found that no distinct reactivity was present for 
any of the growth pattern within either BA or BAC. 100% cases of both BAC and BA 
showed  intense  reactivity  with  CK  in  cells  bordering  lumina,  pseudolumina  and 
occasionally in peripheral cells. Vimentin showed reactivity in 78% BACs and 73% 
BAs, whereas SMA showed positivity in 83% BACs and 91% BAs. Reactivity with 
vimentin and SMA were prominent within the stromal elements and many peripheral 
tumor cells in which vimentin demonstrated basilar dot like reactivity in peripheral 
cells and showed cytoplasmic reactivity within many remaining tumor cells whereas 
GFAP exhibited only faint staining in a few scattered tumor cells in 18% cases of BA 
and 13% cases of BAC. The authors stated that though IHC markers were not useful 
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in  differentiating  BAC  from  BA  due  to  their  similar  IHC  differentiation,  this 
immunoprofile  prove  to  be  useful  in  distinguishing  BAC  from  other  malignant 
salivary and non salivary neoplasms.
de Araujo  et al in 199416 compared the staining patterns of  7 cases of PA, 7 
cases of ACC, 2 cases of MA and 6 cases of PLGA to immuno markers vimentin and 
actin. The authors have found that in PAs, vimentin was detected in almost all the 
nonluminal  cells  (polygonal,  spindle  shaped and hyaline or  plasmacytoid cells)  in 
which  the  staining  was  weak  in  the  clear  polygonal  cells  and  strong  in  the 
plasmacytoid cells whereas actin stained only the outer cells of the ducts and faintly 
stained the polygonal cells.  In cases of ACC, tubular growth pattern showed both 
vimentin and actin staining in the narrow band of cytoplasm of the outer tubular cells. 
The cribriform growth pattern showed that the cells lining pseudocysts and peripheral 
cells of cylinders were stained positively for both vimentin and actin, whereas in solid 
growth pattern with central necrosis, neither vimentin nor actin was detected in tumor 
cells. 
      The growth patterns in PLGA (lobular, trabecular and papillary) were positive for 
vimentin  whereas  out  of  6  cases  studied,  2  cases  showed  staining  (weaker  than 
vimentin) for actin and 4 cases were negative for actin. The authors also showed that 
BAs expressed vimentin in nonluminal cells including duct like structures and luminal 
cells  in  some  cases,  whereas  actin  reactivity  was  negative.  Finally,  the  authors 
suggested that vimentin could be useful to investigate myoepithelial participation and 
distribution in salivary gland tumors.
Ferreiro et al  in 199417investigated 6 CAs, 5 PLGAs and 6 ACCs with a 
panel of immuno markers including AE1/AE3, vimentin, GFAP, S-100, EMA, CEA 
and MSA. The authors have found that all CAs showed strong cytoplasmic positivity 
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to AE1/AE3 and strong reactivity to vimentin in abluminal cells of tubules or canals 
and stroma whereas only one had focal cytoplasmic GFAP staining. All PLGAs and 
ACCs showed positive staining with AE1/AE3 and vimentin but negative staining 
with GFAP. Finally, the authors summarized that IHC may be useful as an aid in the 
differential diagnosis of CA.
Shrestha et al in 199418 evaluated the IHC of 14 cases of CCC using CK 
(K1.1 and K8.12), vimentin, S-100 alpha and beta subunits, NSE, GFAP, MAM-3, 
MAM-6 and PCNA, Ly, LF and alpha 1-Ach. The authors have found that H/P of the 
carcinoma was  characterized  by round or  polygonal  tumor  cells  growing in  solid 
sheets, small nests or cords with collagenous stroma. The clear cells had nuclei with 
little pleomorphism and few or no mitotic figures. The authors showed that and CK 
was present in few tumor cells with almost negligible to strong reaction in all cases, 
vimentin in 6 cases, GFAP in 5 cases with multiple-expression of cytokeratin K8.12, 
vimentin  and  GFAP  in  5  cases.  S-100  protein  immunoreactivity  was  the  most 
prominent feature with more intense reaction. 
Takai et al in 199519 selected 14 cases of PA for IHC evaluation of vimentin, 
GFAP,  CK14  and  MSA  expression.  The  authors  showed  that  100%  cases  were 
extensively positive for vimentin with staining expressed in nonluminal tumor cells of 
all  morphological  types including plasmacytoid cells.  In plasmacytoid cells,  either 
entire cytoplasm was intensely stained or the cytoplasm contained pale round zone 
enclosed by a rim of strong positive cytoplasm. The degree of cytoplasmic staining 
for vimentin was strong in majority of nonluminal cells than luminal cells and out of 
14 cases, only 4 cases failed to express vimentin in luminal cells. With GFAP, 94% of 
PA had  a  significant  population  of  positive  nonluminal  cells  (plasmacytoid  cells, 
stellate to spindle shaped cells in myxoid material). The cytoplasmic distribution of 
GFAP in  plasmacytoid  cells  in  PA was  either  diffused  or  surrounded  by weakly 
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stained central region as noted with vimentin and 6/14 (43%) cases showed positivity 
in luminal cells.             
Mccluggage et al in 199520 studied a case of BAC using the immune markers 
SMA,  CAM  5.2,  S-100  and  CEA.  The  authors  have  found  that  the  tumor  cells 
(smaller cell type) showed focal positivity for SMA mainly around the periphery of 
the cell groups, although small numbers of cells within the centers of the groups also 
showed positive staining. The authors stated that this staining pattern supported the 
concept  that  the  cells  showing  myoepithelial  differentiation  were  present  in  the 
malignant counterpart of BAC.    
Seifert et al in 199621 studied halinizing CCC using the immune markers CK, 
S-100,  actin,  EMA  and  CEA.  The  authors  have  found  that  the  tumor  was 
histopathologically characterized by solid or trabecular formations of polygonal clear 
cells  which  are  surrounded  by  a  broad  hyalinized  desmoplastic  connective  tissue 
stroma. The clear cells expressed CK but not S-100 protein, actin or other markers of 
myoepithelial cells.
Savera  et al in 199722 analysed immunoreactivity of 65 cases of PA to α-
SMA, SMMH and calponin. The authors have classified different cell types within the 
PAs as inner tubular epithelial cells, myoepithelium-like cells (juxtatubular, cuboidal, 
and spindle), modified myoepithelium (myxoid, chondroid, hyaline), and transformed 
myoepithelium  (solid  epithelioid,  squamous,  basaloid-cribriform).  The  authors 
showed that 94% of their cases reacted with α-SMA and the staining was limited to 
the myoepithelial-like cells,  whereas modified and transformed myoepithelial  cells 
lacked  these  myofilaments  and  thus  α-SMA  is  expressed  only  in  the  well 
differentiated neoplastic myoepithelium. None of the smooth muscle markers stained 
the inner-tubular epithelial cells. Hence, the authors found that the expression of α-
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SMA  in  the  neoplastic  myoepithelium  is  to  be  associated  with  the  state  of 
morphologic differentiation and calphonin is the most sensitive marker of neoplastic 
myoepithelium. 
                Gnepp et al in 199723 evaluated the GFAP localization in 12 cases of PA 
and  12  cases  of  PLGA.  The  authors  found  that  2  cases  of  PLGA  showed  focal 
positivity only in the epithelial component and staining did not occur in the stroma. 
The authors also showed that in PA, all the 12 cases showed positive reactivity in 
stromal component in which only 5 cases showed positivity in epithelial component 
with weak and focal staining. In stromal component, majority of staining was seen in 
the periductal cells and in the plump to spindle mesenchymal like cells. Finally, the 
authors concluded that the positive staining in mesenchymal like cells equates the 
diagnosis of PA, whereas the epithelial but not the stromal component in PLGA may 
occasionally stain with GFAP, on the other hand the negative does not indicate a 
diagnosis of PLGA since occasional PA may have GFAP reactivity. In such situation, 
the authors suggested that other histopathologic criteria need to be used to establish 
the proper diagnosis.  
  Perez Ordonez et al in 199824 performed histopathlogical study as well as 
IHC study with vimentin, SMA, GFAP and few other immunostains in 16 cases of 
PLGA. The authors have found that the uniform cytology of PLGA indicated the low-
grade malignant  cytological  features  rather  than different  cell  types  forming these 
neoplasms. The neoplastic cells in PLGA composed of small cuboidal luminal cells 
and round, polygonal and spindle or oval nonluminal cells were usually observed in a 
combination  of  five  basic  architectural  patterns  including  tubules  and  duct  like 
structures,  cords  and  trabeculae,  solid  nests,  cribriform areas  with  pseudoluminal 
spaces and papillae. 
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The authors have found that vimentin was positive in all cases where all cell 
types  showed  intense  reactivity  except  for  single  case.  With  SMA,  staining  was 
negative in 13 cases, weakly positive in 1 case and moderately positive in 2 cases with 
positive cells seen on the periphery of the nests and some solid cords whereas GFAP 
was focally present in only one case and thus the authors demonstrated a total absence 
of  GFAP  and  actin-positive  cells  in  most  cases  of  PLGA.  Finally  the  authors 
suggested that the luminal cells exhibits ductal type differentiation showing moderate 
or strong reactivity to LMK and vimentin and only occasional reactivity to HMK. In 
contrast,  the  nonluminal  cells  showed  a  phenotype  consistent  with  basal  cell 
differentiation  and  less  commonly  with  myoepithelial  cells  demonstrating 
immunoreactivity to LMK, HMK, vimentin and SMA. 
  Ikeda et al in 199825 studied a case of BAC using the immuno markers CK, 
vimentin, SMA, EMA, CEA and S-100. The authors showed that all of the cells were 
reactive for CK and vimentin with focal reactivity for SMA. 
Prasad et al in 199926 analysed 26 PLGAs, 13 ACCs, 17 CAs, 6 SDCs and 9 
oncocytomas with the use of immuno markers SMA, SMMHC and calponin.  The 
authors  found  that 100%  cases  of  ACC  showed  reactivity  with  α-SMA.  In  the 
cribriform  growth  pattern,  small  basophilic  neoplastic  myoepithelial  cells  with 
angular nuclei lining the pseudocystic structures and forming contiguous solid growth 
pattern  exhibited  a  narrow band of  cytoplasmic  positivity  for  α-SMA whereas  in 
tubular growth pattern with double layers,  the cuboidal inner epithelial  cells  were 
negative to α-SMA and the abluminal myoepithelial cells reacted intensively with α-
SMA. Thus, there was unambiguous myoepithelial participation in all growth patterns 
of these tumors. 
In contrast, none of the tumor cells of PLGA showed any reactivity with α-
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SMA,  because  the  cells  lining  the  periductal  and  pseudoadenoid  pattern  in  these 
tumors lack myofilament expression and were more closely related to basal ductal 
cells.  However,  the  chances  of  false  positivity  may result  due  to  the  presence  of 
myoepithelial  cells  of  entrapped,  non  neoplastic  salivary  acini  and  peripherally 
located  stromal  fibroblasts.  Thus,  there  was  no  evidence  of  myoepithelial 
differentiation in any histologic pattern in these tumors. All CAs were negative to α-
SMA  whereas  in  SDCs,  some  of  the  ductal  structures  (residual  non-neoplastic 
myoepithelium of native glands) retained a peripheral  rim of myoepithelium, tight 
cuff of myofibroblasts and dysplastic stromal cells which reacted with α-SMA and the 
tumour cells were nonreactive. All cases of oncocytoma were entirely negative for 
muscle  markers.    Finally,  the authors  concluded that  the consistent  difference of 
immunostaining patterns between PLGA and ACC have diagnostic significance. 
Quddus et al, in 199927 studied 3 cases of BACs by means of IHC using AE1/
AE3, SMA, vimentin, EMA, CEA, p53, Ki-67, S-100, GFAP and c-erb-B2. The
authors  have found that  all  3  tumors  stained with SMA were  strong positivity in 
peripheral tumor cells of the nests in the solid growth pattern whereas tumor cells 
towards the center showed weak positivity. The trabecular growth pattern revealed 
multifocal to diffuse staining confined to cells at the margins of the cords of tumor 
cells.
The authors also found that the immunoreactivity of vimentin was similar in 
all the 3 tumors with diffuse intense staining of the tumor cells, CK (AE1/AE3) also 
stained all  the 3 tumors more peripherally in the solid growth pattern and usually 
centrally in the trabecular growth pattern. inally, the authors have concluded that the 
degree and type of differentiation, proportion, and arrangement of tumor cells were 
responsible for the variability of the staining in the different histologic patterns.
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Michal et al  in 199928 evaluated 8 cases of adenocarcinoma of the tongue 
using  the  immuno  markers  CK  (AE1/AE3,  CAM  5.2),  SMA,  S-100,  MSA  and 
thyroglobulin.  The  authors  have  found  that  on  H/P  study,  solid,  microcystic  and 
tubular  growth  patterns  were  seen.  Solid  areas  contained  tumor  cells  with 
hyperchromatic  peripheral  layer  which  displayed  peripheral  palisading  and  also 
retraction  clefts  around  the  islands.  Microcystic  growth  pattern  was  composed  of 
lobules  of  neoplastic  cells  with  cribriform  or  single  layered  tubular  structures. 
Cytologically,  tumor cells were characterized by overlapping, single pale vesicular 
nuclei with ground glass appearance and clear to oxophilic cytoplasm. The authors 
also showed that IHC revealed strong reactivity of tumor cells to CK AE1/AE3 and 
strongest positivity to SMA in cribriform areas with spindle shaped cells.
Synder and Paulino in 199929 studied a case of hybrid carcinoma composed 
of 80% SDC and 20% ACC using the immuno markers CK, vimentin, SMA, ER, PR, 
BRST-2 and S-100. The authors have found that on H/P study, the classiccribriform 
pattern of ACC containing basaloid tumor cells with angular nuclei, small nucleoli, 
scant eosinophilic cytoplasm and indistinct cells borders was present at the periphery. 
The cyst like spaces contained pale basophilic material as well as eosinophilic basal 
lamina  material.  There  were  solid  nests  of  pleomorphic  cells  with  central 
comedonecrosis and occasional dystrophic calcification. Mitotic figures were readily 
identified.
The  authors  also  showed  that  SDC  component  was  positive  for  CK  but 
negative  for  SMA whereas  in  ACC, the  inner  layer  was  positive  for  only CK in 
contrast  to  the outer  layer  which was negative for CK but  positive for SMA and 
vimentin.  The authors concluded that when some histological features of different 
salivary  gland  tumors  overlap,  IHC was  used  as  a  valuable  tool  to  delineate  the 
28
components of a hybrid tumor.
Berho et  al  in  199930 described  the  IHC pattern  of  two cases  of  primary 
intraosseous hyalinizing CCCs of the jaws to CKs AE1/AE3, SMA, vimentin, S-100, 
CEA, CAM 5.2 and EMA. The authors have found that the lesions were composed of 
sharply  demarcated  solid  islands,  trabeculae,  and  cords  growing  with  infiltrative 
borders and characteristic heavily hyalinized fibrous stroma. At the periphery of the 
lesions, cords and small nests of neoplastic cells were seen between the remaining 
bony trabeculae. Two cellular phenotypes were noted where majority of the cells were 
polyhedral  or  round  with  cytoplasmic  clearing  containing  small  centrally  located 
nuclei and the other cell type was smaller cells having an eosinophilic and granular 
cytoplasm.  The authors showed that  in both cases the majority of the cells showed 
strong cytoplasmic staining with AE1/AE3. In both cases vimentin stain was positive 
in the stromal cells and negative in the neoplastic cells whereas S-100 and SMA were 
uniformly negative.
Rezende et al in 199931 analysed the IHC staining of 3 cases of CCASG using 
CKs, S-100, SMA, vimentin, GFAP, CEA and EMA. The authors showed that all the 
3 cases were negative to S-100, SMA, vimentin and GFAP.
 Foschini  et  al  in  200032 stated  that  myoepithelial  cells  are  contractile 
elements showing a combined epithelial and smooth muscle phenotype. They found 
that among the  IHC markers, SMA, calphonin, SMM and heavy caldesmin employed 
to detect myoepithelialcells, SMA is the most widely used marker. The reactivity of 
smooth muscle markers is variable in the major and minor salivary glands. In minor 
salivary glands, all the four markers were equally strongly expressed. Although SMA 
is the most widely used in identifying the myoepithelial cells, it also stains stromal 
myofibroblasts, sometimes hampering the identification of myoepithelial cells. 
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 Zarbo et al in 200033 studied 11 cases of CA and 14 cases of BA with use of 
α-SMA, SMMH, and calponin. The authors have showed that BAs were sub classified 
as members of the variants, trabecular-tubular, trabecular, tubular, membranous and 
solid. Except one trabecular-tubular variant, all other BAs contained cells highlighted 
by α-SMA and of the tubular variant, positively stained cells were seen in tumors 
composed  of  single  layered  tubules  and  bilayered  tubules.  In  the  trabecular  and 
trabecular-tubular adenomas, the tumor cells at the peripheral stromal interface that 
formed  trabeculae  showed  myoepithelial  differentiation  contrast  to  the  central 
basaloid  cells  within  the  trabeculae.  In  addition,  the  stromal  like  spindled 
myoepithelial  cells  in  between  trabeculae  also  stained  positive  in  the  trabecular-
tubular  type.  In  the  solid  type,  peripheral,  palisading  dark  cuboidal  cells  stained 
positively whereas in membranous type, in addition to this staining pattern, the cells 
surrounding the hyaline cylinders within solid tumor islands also stained positively 
for α-SMA. The authors also showed that CA was negative for α-SMA and thus, with 
the exception of CA, all exhibit some degree of myoepithelial cell participation.
  de Araujo et al in 200034applied a panel of antibodies composed of CKs, 
vimentin, and actin to 114 minor salivary gland tumors. The authors have revealed 
that luminal cells of intercalated duct like structures seen in PA, BA, ACC and EMC 
expressed CKs 7,8,14 & 19 whereas the outer cells of the duct like structures in PA, 
BA and ACC exhibited  vimentin.  Finally the  authors  suggested  that  the  panel  of 
antibodies employed is effective in distinguishing among salivary gland tumors.
 Kaneko et al in 200035 studied IHC of EMC using PK, S-100, SMA, GFAP, 
vimentin, EMA, NSE, amylase, LF and SC. The authors have found that the clear 
cells  in  both  solid  and  tubular  growth  patterns  reacted  with  S-100,  GFAP,  and 
vimentin and had diastase-soluble PAS granules in their cytoplasm.
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Scarpellini et al in 200136 have used IHC to study a series of 23 benign and 
malignant  tumors  (PA,  BA,  ACC,  EMC and  myoepithelioma)  using  the  markers 
SMA,  calponin,  caldesmin  and  SMMHC.   The  authors  have  found  that  all  their 
tumors  showed positivity to  atleast  one  of  the  myoepithelial  marker  and of  these 
markers,  SMA  was  expressed  most  frequently.  Staining  was  found  in  the 
myoepithelial  cells  that  formed  the  outer  cell  layers  of  the  glandular  or  tubular 
growth. Finally, the authors concluded that this panel of myoepithelial markers helps 
to disclose myoepithelial cell differentiation and can be a useful tool for the correct 
histopathological  diagnosis  of  salivary gland tumors  and among  the  four  markers 
studied,  calponin  and  SMA  were  the  most  useful  to  identify  myoepithelial  cell 
differentiation.
Lopes et al in 200137 described an intraoral SDC with H/P features of large 
duct like structures lined by pleomorphic cells with central comedonecrosis. The cells 
were cuboidal with round, clear nuclei, and prominent nucleoli and showed numerous 
atypical  mitotic  figures.  The growth  patterns  observed were intraductal,  solid  and 
cribriform. The authors performed IHC study in this case with the markers CK, EMA, 
PCNA, Ki-67, collagen IV and laminin and showed that SDC was positive to CK.
Curran et al in 200138 studied 36 cases of PA and 42 cases of PLGA (minor 
salivary gland tumors) with GFAP. All PLGAs demonstrated tumor mass that was 
unencapsulated,  partially circumscribed,  and peripherally infiltrative arranged most 
commonly in solid and tubular growth patterns alone or in combination, whereas 3 
cases contained a few areas with a papillary configuration and only 13 cases showed 
cribriform growth pattern.  The stromal component was most commonly a densely 
fibromyxoid type. All PAs were completely or partially encapsulated containing both 
epithelial and myxomatous areas showing cuboidal to polygonal cells and spindled or 
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stellate  cells  respectively whereas  12  cases  had  prominent  or  scattered  chondroid 
areas. The authors have shown that over 50% of cells showed positive reaction to 
GFAP in 66% of PA, and the remaining 33% of the cases exhibited less than 50% of 
positive cells. In PLGA, though 73% of cases failed to react with GFAP, remaining 
23% cases had faint and spotty staining that was mainly confined to the less numerous 
medium-sized polygonal cells rather than the ovoid cells that comprise the bulk of the 
lesion. The authors stated that minor gland lesions differ from major gland lesions in 
that they are more often cellular, lacking a prominent fibrous capsule, and containing 
scant or absent myxoid and chondroid material and hence, the use of GFAP should be 
considered  for  differentiation  of  PLGA  versus  PA  when  there  was  overlapping 
architectural,  background,  and  cellular  features  in  the neoplasm of  minor  salivary 
glands.
Machado de Sousa et al in 200139 analysed 3 cases of BA and 3 cases of CA 
with CKs 7, 8, 13,14, and 19, vimentin and MSA. The authors have found that in 
cases of BA, outer cells in duct like structures were stained with vimentin in contrast 
to the solid areas, which showed negative reactivity. None of the CA was reactive 
with vimentin. 
Penner et al, in 200240 analysed c-kit expression in 9 cases of ACC and 14 
cases of PLGA. The authors have found that c-kit was expressed by 100% of ACC 
compared to 57% of PLGA cases. The cribriform and tubular growth patterns in ACC 
showed positivity in inner cell layers (luminal cell layer) of the tumor, while the solid 
growth  pattern  expressed  c-kit  in  all  cells,  most  of  which  were  thought  to  be  of 
modified myoepithelial cells. The authors also showed that the expression of c-kit in 
PLGA was very focal and greatly decreased when compared with ACC. Finally, the 
authors consider that the use of c-kit may be helpful in the differential. 
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 Chhieng et al in 200241studied about BA, BAC, cellular PA and ACC using 
the immunostains CK, GFAP, chromogranin, LCA, CD 99 and desmin. The authors 
have found that the stromal cells in PA and myoepithelial cells in ACC were positive 
for  GFAP,  whereas  PLGA,  BA  and  BAC  were  negative  to  GFAP.  Finally  they 
suggested  that  consideration  of  cytological  features  along  with  the  architectural 
pattern aided by IHC was essential to arrive at an accurate diagnosis.
           Nagao et al in 200242 studied 9 cases of hybrid carcinoma which also includes 
BAC, SDC and ACC using the immuno markers AE1/AE3, SMA, vimentin, CAM 
5.2, S-100, CEA, p53, EGFR, c-erbB-2, GCDFP-15 and MIB-1. Their BAC showed 
diffuse positivity to AE1/AE3 compared to SMA and vimentin which were restricted 
to the periphery in the solid growth pattern. SDC was frequently immunoreactive for 
AE1/AE3 but negative for SMA and vimentin whereas in ACC, vimentin and SMA 
were positive.  
Wang et al in 200243 studied 20 cases of salivary primary clear cell tumors 
including 12 CCCs, 7 EMCs and 1 CCMEC CK, S-100, calponin and MSA. The 
authors have found that CCC appeared as islands and sheets of tumor cells with clear 
cytoplasm admixed  with  some  pink  cytoplasmic  smaller  cells.  Tumor  cells  were 
relatively  pleomorphic  with  high  nuclear-cytoplasmic  ratios  and  dark,  condensed, 
eccentric nuclei. Collagen deposition is variable and no hyaline cells were seen. The 
authors  showed that  S-100 expression was strong in 1 case of  CCC and weak to 
moderate in 2/8 cases of CCC.
Mino  et  al  in  200344evaluated KIT  (antibodies-H300  and  A4502)  IHC 
reactivity in head and neck neoplasms including 53 cases of ACC, 16 cases of PA, 5 
cases of AC, 4 cases of SDC and 8 cases of PLGA. The authors found that 94% of 
ACC were  positive  for  atleast  one  of  the  two antibodies  and 77% of  cases  were 
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positive for both antibodies. Tubular, cribriform and mixed subtypes of ACC showed 
a distinct IHC pattern (more pronounced in tubular subtype) of luminal epithelial cell 
positivity  with  peripheral  myoepithelial  cell  negativity  and  solid  subtype 
demonstrated  a  diffuse  staining  pattern.  KIT  expression  was  lowest  among  the 
cribriform subtype and highest among the tubular and solid subtypes of ACC.
 The authors also showed that the PA, BA and PLGA showed little expression 
of  KIT  and  BAC  showed  slightly  increased  KIT  expression  with  strong  diffuse 
staining.BAC  had  a  heterogenous  pattern  reminiscent  of  the  tubular  and  mixed 
subtypes of ACC. The authors suggested that the expression of KIT was potentially 
useful in distinguishing ACC from PA, BA, PLGA, BAC and basal cell carcinoma.
Edwards et al in 200345 studied 17 cases of PLGA, 17 cases of MA and 15 
cases of ACC with c-kit. The reactivity was uniformly positive in the cytoplasm of 
luminal neoplastic cells in all cases of ACC with more prominent expression  in solid 
variant and the intensity of staining was strongest in ACC of minor salivary gland 
origin.  The  authors  also  have  found  that  regarding  PLGA,  16  (94%)  cases  were 
reactive for c-kit with atleast 25% of the tumor cells being positive (faint focal to 
strong reactivity) and the overall intensity of staining was weaker in PLGA than in 
ACC. MAs also showed reactivity similar to PLGA with positivity in 16 (94%) cases 
and expression was observed in  luminal cells  similar  to  ACC. Finally the authors 
consider  that  the  utility  of  c-kit  may not  be  helpful  in  distinguishing  ACC from 
PLGA.
Hemachandran et al in 200346 studied a case of BA with pancytokeratin, 
SMA, vimentin,  S-100 and CEA. The authors found that there was diffuse strong 
positivity for pancytokeratin shown by the tumor cell within the islands whereas SMA 
positivity  was  noted  in  the  palisading  basaloid  cells  and  vimentin  positivity  was 
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observed in the stromal cells. The authors stated that strong positivity for cytokeratin, 
SMA, and S-100 protein was noted in the epithelial cell component, indicating the 
myoepithelial nature of this tumor cells. 
Furuse et al in 200347 analyzed 5 CAs and 10 PLGAs with the use of SMA, 
vimentin, CK7, CK8, CK13 and CK14 immuno markers. The authors have found that 
PLGAs located in the upper lip were composed of a single layer of columnar cells 
arranged  in  channels  resembling  the  H/P  feature  of  CA.  They  found  negative 
reactivity in CA with SMA and vimentin.  In cases of PLGA, vimentin stained all 
columnar  cells  and  SMA  was  negative.  Finally,  the  authors  concluded  that  the 
positivity of PLGA to vimentin was the best means to differentiate the two entities. 
Nagao et al in 200348studied IHC staining of 6 cases of dedifferentiated ACC 
using CK AE1/AE3,  α-SMA, GFAP, S-100, EMA, MSA, CEA, HER-2/neu,  p53, 
pRb, cyclin D1 and Ki-67. The authors stated that the dedifferentiated ACC was a rare 
variant  of  ACC  which  was  characterized  histologically  by  two  components, 
conventional  low-grade  ACC  and  high-grade  ‘dedifferentiated’  carcinoma.  The 
conventional low-grade ACC consisted of a mixture of cribriform and tubular patterns 
with scant solid areas whereas the high-grade dedifferentiated carcinoma was either a 
poorly differentiated adenocarcinoma or undifferentiated carcinoma.
The authors have found that low-grade ACC component showed positivity 
to AE1/AE3 in the cells located mainly on the inner (luminal) aspect of cells nests and 
to α-SMA in the abluminal tumor cells adjacent to connective tissue. In contrast,
dedifferentiated carcinoma expressed diffuse immunoreactivity to AE1/AE3 and was 
negative to α-SMA staining. GFAP was negative in all cases.
Matsuzaka et al in 200449 reported a case of CA and its immunoreactivity 
with AE1/AE3, GFAP, SMA, vimentin, S-100, CK 7, 8, 13, 14 & 19 and PCNA. The 
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authors showed that the tumor cells were positive for AE1/AE3, partially positive for 
GFAP and negative for SMA and vimentin.
Nagao et al in 200450 analysed the IHC of 3 cases of PLGA using the markers 
CKs AE1/AE3,  vimentin,  α-SMA, S-100,  CKs 7,  20  & 34bE12,  EMA, CEA,  E-
cadherin,  HER2/neu,  MSA,  Ki67  and  p53.  They  found  that  all  the  tumors  were 
positive for AE1 ⁄ AE3 and negative for α-SMA and GFAP. They also showed that 
tumor cells in all cases had a diffuse immunoreactivity for vimentin.
Sicurella  et  al  in  200451 analysed  the  IHC  of  a  case  of  CCC  using  CK 
AE1/AE3, S-100, SMA and vimentin. The authors have found that the neoplastic cells 
were intensely positive for AE1/AE3 and negative for S-100, SMA and vimentin.
Sun et al in 200552 investigated a case of hyalinizing CCC using the immuno 
markers  CK AE1/AE3,  S-100 and α-SMA. The authors  showed that  on  H/P,  the 
tumor cells were arranged in solid cell nests, trabeculae, islands or cords surrounded 
by a prominent hyaline stroma and occasional foci of myxoid stroma. Among the two 
types of cell populations found, the vast majority of the tumor cells were round to 
polygonal  with  clear  periodic  acid-Schiff  (PAS)  positive  cytoplasm and the  other 
population  was  smaller  and  consisted  of  plump  nuclei  and  granular  eosinophilic 
cytoplasm. Both populations of tumor cells lacked nuclear pleomorphism, and mitoses 
were very scarce. The authors also found that all the tumors were positive for CK 
AE1/AE3 and negative for S-100 and α-SMA.
Freier et al in 200553 studied KIT expression in 55 cases of ACC. The authors 
showed that the prevalence of positive KIT immunostaining in ACC was 89%. Of the 
different  growth  patterns,  the  tubular  growth  pattern  showed  100%  positivity  in 
contrast to 92% positivity in cribriform growth pattern and 75% positivity in solid 
growth pattern. The staining intensity of reaction was strong in cribriform and tubular 
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subtypes and weak in solid subtype. The authors stated that KIT immunostaining was 
more  frequently  found  in  well-differentiated  tumors  and  might  get  lost  during 
dedifferentiation  of  ACC,  indicating  that  different  molecular  pathways  could  be 
involved in the formation of histological ACC subtypes.
Margaritescu et al in 200554 have done IHC evaluation of 4 salivary gland 
BA using AE1/AE3, vimentin, SMA, CK19, CEA, S-100 and PCNA. The authors 
showed that the positive reaction to vimentin was present in all the investigated cases 
with variable intensity. Both the epithelial and stromal components showed positivity 
and the reactivity of epithelial component was limited only to some of the basaloid 
cells from the periphery of epithelial neoplastic proliferations that corresponded to the 
dark basaloid cells observed in routine light microscopy. In epithelial component, less 
than  20%  cells  were  positive  with  weak  to  moderate  intensity  whereas  stromal 
component  showed reactivity  in  interstitial  fibroblasts  and stellate  shaped cells  in 
myxoid areas. 
With SMA, staining pattern was similar to vimentin in epithelial component 
but the light basaloid cells and luminal ductal cells were negative. In stromal areas 
with myxoid differentiation, fusiform cells with myoepithelial-like morphology were 
observed with weak intensity. The reactivity to AE1/AE3 was confined to tumoral 
epithelial component with intense reactivity in luminal ductal cells (tubular growth 
pattern) and positivity was observed in 75% of cells. The authors also noticed that 2 
cases  of  solid  growth  pattern  showed  positive  reaction  to  AE1/AE3  with  weak 
intensity in dark basaloid cells. All the 3 markers exhibited homogenous cytoplasmic 
staining pattern.
Furuse et al in 200555 compared the immunoexpression of 5 myoepithelial 
cell markers, α-SMA, vimentin, calponin, h-caldesmon and S-100-protein in 16 PAs, 
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15 ACCs and 3 EMCs of salivary glands. The authors have found that in PAs, α-SMA 
was observed mostly in nonluminal cells of the duct-like structures, spindle shaped 
cells and some cells of the chondroid areas whereas polygonal, plasmacytoid and star-
shaped cells of the myxoid stroma were negative to SMA. In contrast, vimentin was 
expressed by most of the myoepithelial cells, regardless of their phenotype.
 The authors also showed that in ACC, tubular type exhibited reactivity to 
SMA and vimentin in outer tubular cells whereas in cribriform type,  cells lining the 
cyst-like spaces and peripheral cells of the arrangements stained positively for α-SMA 
and vimentin.  Solid type of ACC showed negativity to SMA and slight positivity to 
vimentin, being strong only in few cells.  The authors have concluded that α-SMA 
was  useful  for  identification  of  myoepithelial  cells,  especially  in  cribriform  and 
tubular ACC while polygonal and plasmacytoid cells of PA and solid ACC showed 
negativity with α-SMA.
Andreadis et  al  in  200656 in  their  IHC analysis  of  20 PAs,  14 ACCs, 14 
PLGAs, 1 oncocytoma, 3 SDCs and 1 BA using a polyclonal c-kit antibody observed 
that in normal salivary glandular tissues, c-kit showed weak expression in intercalated 
and striated ducts of major and minor salivary glands whereas mucous; myoepithelial 
and oncocytic cells were negative. The authors have found that 80% cases of ACC
were positive for c-kit with strong expression in almost all neoplastic cells of the solid 
growth pattern, the luminal cells of tubular structures and the inner layer of cells 
lining pseudocystic spaces of cribriform growth pattern.  PLGA showed expression 
more frequently in the luminal and less often in the nonluminal cells. In ACC, more 
than 50% of neoplastic cells were positive in contrast to PLGA in which less than 
50% of neoplastic cells were positive for c-kit. The authors also found that in BA, 
10-25% of cells of all structures were membrane stained for c-kit in a non-specific 
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manner and all cases of PA showed moderate (25-50%) mainly, membrane positivity 
exclusively of the inner luminal neoplastic cells of the duct-like structures whereas the 
tumor cells in solid, trabecular or reticular areas were negative. Oncocytic adenomas 
and SDCs were negative for c-kit whereas neoplastic cells in the center of the solid 
islands  of  BA  were  positive  for  c-kit.  Finally,  the  authors  concluded  that  c-kit 
expression was used in differential diagnosis of ACC and other subtypes of salivary 
gland neoplasms. 
Beltran et al in 200657 studied 10 cases of PLGA and 12 cases of ACC with 
the immuno markers c-kit,  SMA, Ki-67 and MSA. The authors showed that  c-kit 
staining  in  PLGA was  negative  in  8  cases,  weak in  1  case  and strong in  1  case 
whereas ACC showed staining in luminal cells in all 12 cases with weak staining in 5 
cases and strong in 7 cases. The authors also showed that SMA expression in PLGA 
samples were negative in 5 cases, weak in 2 cases and strong in 3 cases and ACC 
samples showed negativity for SMA in 2 cases of solid histologic variant and strong 
staining in abluminal cells (myoepithelial cells) in 10 cases. The authors concluded 
that c-kit and SMA were potential adjunctive diagnostic tools in differentiating PLGA 
from ACC in histologic sections.
Albores-Saavedra et al in 200658 studied the immunoreactivity of 2 cases of 
sclerosing variants of ACC with AE1/AE3, SMA, vimentin, S-100 and collagen IV. 
The authors found that the predominant myoepithelial cells showed immunoreactivity 
for SMA and vimentin and negativity to AE1/AE3. In contrast, the epithelial cells that 
lined ductal structures were negative for SMA and vimentin and positive to AE1/AE3.
  Epivatianos et al in 200759 analysed IHC expression of vimentin, SMA and 
c-kit in 12 cases of ACC and 12 cases of PLGA. The authors stated that  ACC and 
PLGA are distinct types of salivary gland adenocarcinomas with different prognosis 
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but due to overlapping histological features (tubular/ductular and cribriform growth 
patterns) may occasionally result in a diagnostic pitfall complicating the therapeutic 
decision making. In these cases, the authors employed IHC to support the histological 
diagnosis  with  the  use  of  a  panel  of  markers  (c-kit, α-SMA  and  vimentin). The 
authors have found the expression of c-kit in both ACC (83%) and PLGA (41%) with 
more than 50% of c-kit positive cells in ACC and less than 50% of c-kit positive cells 
in over 80% and 40% of ACC and PLGA respectively. They also found different IHC 
reactivity pattern in ACC and PLGA. In ACC, staining was limited to the luminal 
cells  of the ductular pattern and staining was uniform in all  cells  of solid growth 
pattern. On the other hand, PLGA showed reactivity in both luminal and non-luminal 
cells of ductular, trabecular and lobular growth patterns. The authors have also found 
that 100% of both ACC and PLGA showed positivity with vimentin. In ACC, the 
expression  was  limited  to  the  nonluminal  cells  of  tubular  and  ductular  growth 
patterns,  and in  the  tumor  cells  lining  the  pseudocysts  and proper  tumor  cells  of 
cribriform structures whereas expression of vimentin  in PLGA was observed in the 
nonluminal cells of lobular, ductular and trabecular growth patterns, tumor cells lining 
the pseudocysts, dispersed proper tumor cells in cribriform structures. In the other 
growth patterns of PLGA, staining was variable. The expression of α-SMA in ACCs 
(100%) were similar to vimentin with moderate to strong intensity, while in PLGA, 
25% of cases were positive with reactivity limited to the luminal and nonluminal cells 
of ductular and tubular growth patterns, central and peripheral cells of the solid and 
fascicular growth patterns and single layer cells of ductular and tubular structures. 
Finally, the authors concluded that use of α-SMA and c-kit may offer an adjunctive 
aid in differential diagnosis of ACC and PLGA.
Cavalcante et al in 200760 analysed immunoreactivity of 12 cases of PA, 8 
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cases of ACC and 4 cases of PLGA to vimentin, calponin and HHF-35. The authors 
have found that vimentin was expressed in all cases of PA and PLGA and 62.5% 
cases of ACC and its  expression was diffuse in all  tumours.  In PA, the vimentin 
immunostaining  was  concentrated  in  almost  all  nonluminal  cells  ,  including 
polygonal, spindle-shaped, hyaline and plasmacytoid cells, located at the periphery of 
the  sheets,  nests,  cords,  tubules  or ducts.  Chondroid  matrix  cells  were  intensely 
stained for vimentin and no staining of luminal cells was observed. In PLGA, focal 
staining was observed mainly in nests and cords and also in trabeculae and cells lining 
the pseudocysts of cribriform growth pattern. In ACCs, vimentin immunoreactivity 
was mainly observed in cells delimiting the pseudocystic structures and occasionally 
in nonluminal cells of tubules and ducts. 
Curran et al, in 200761 examined 27 CAs, 21 PAs, 30 PLGAs and 3 BAs to  
determine their immunoreactivity to GFAP. The authors showed that 26 CAs  
and 3 BAs demonstrated either strong or weak intracytoplasmic reactivity that  
was  confined  to  a  row of  cells  at  the  tumour/  connective  tissue  interface 
whereas one case of CA demonstrated weak diffuse positivity of tumor cells  
but  also  demonstrated  a  row  of  strong  immunoreactive  cells  at  the 
tumor/connective tissue interface and one CA was not reactive. The authors  
also found that all PLGAs showed little or no immunoreactivity to GFAP with  
the exception of occasional faint positivity in luminal cells. Contrast to PLGA,  
all PAs demonstrated either strong or weak cytoplasmic positivity within the  
tumor cells. Additionally, 2 cases of PA demonstrated a weakly linear row of  
immunoreactive cells  at  the  tumor/connective  tissue  interface.  The authors  
stated  that  quantification  of  GFAP  positive  tumor  cells  was  useful  in  
differentiating PA from PLGA but not when differentiating PLGA or PA from  
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CA.  The  authors  suggest  that  the  pattern  of  single  row of  distinct  GFAP 
immunoreactive cells at the tumor/connective tissue interface can be used as a  
reliable diagnostic criterion for differentiating among CA, PLGA and PA.
 Parashar et al in 200762  reported immunoreactivity of 2 cases of BAC with 
SMA, GFAP, vimentin, S-100, Bcl-2, CKs 7 & 20, EMA, CEA and p53. The authors 
showed that fewer than 20% of cells were weakly positive for vimentin in only 1 
tumor and both tumors were negative for GFAP and SMA. 
 Kikuchi et al in 200763 studied a case of SDC using the immune markers CK 
AE1/AE3, SMA, vimentin, CAM 5.2, AR, BRST-2, S-100 and GCDFP-15. On IHC 
analyses, they showed that neoplastic cells were positive for AE1/AE3 and negative 
for SMA and vimentin. 
 Meer and Altini  in 200764 studied 24 PAs, 22 ACCs, 21 PLGAs and 3 SDCs 
using the immuno markers CK 7, CK 20 and CK AE1/AE3. The marker AE1/AE3 
was used as a guideline. They showed that 100% cases of PA, ACC, PLGA and SDC 
were positive for AE1/AE3. 
Di Palma et al in 200765 analysed a case of PA with multiple foci of oncocytic 
metaplasia using the immuno markers CKs 5, 6, 8, 18 & 14, vimentin, α-SMA, p63, 
S-100, β-catenin, EGFR, HER2, Ki-67 and p53. The authors have found that α-SMA 
was positive in the spindle cells and to a lesser extent in the epithelioid components of 
PA. PA was also positive to vimentin. In contrast, α-SMA and vimentin were negative 
in oncocytic cells. Both PA and oncocytic cells were positive to CK 8/18 whereas 
absence of myoepithelial markers in oncocytic foci indicated lack of myoepithelial 
differentiation in oncocytic cells.
Pereira et al in 200766 reported immunoreactivity of a case of CA using 
CKs AE1/AE3, S-100, EMA, CEA, calphonin and p63. The authors have found that 
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most of the cells were positive for AE1/AE3 CKs within the cytoplasm and for S-100 
protein in the outer portions of tubules or canals. Finally they summarized that the 
strong and frequent staining for S100 protein represents the main characteristic of CA.
Suzuki  et  al  in  200767 presented  the  IHC reactivity  of  a  case  of  CCC to 
pancytokeratin (AE1+AE3), S-100, vimentin, GFAP, MSA and SMMH. The authors 
showed that all the tumor cells displayed positive result only for pancytokeratin and 
negative results for S-100, vimentin and GFAP.  
Angiero et al in 200768 reported the IHC of a case of hyalinizing CCC to the 
markers pancytokeratin, SMA, S-100, vimentin, GFAP, EMA, HMB45, CD68 and 
CEA.  The  authors  have  found  that the  neoplastic  cells  were  immunoreactive  to 
pancytokeratin, but negative for SMA, vimentin, S-100 protein and GFAP.
Pujary  et  al  in  200869 investigated  a  case  of  hyalinizing  CCC  using  the 
immuno markers CK AE1/AE3, S-100 and vimentin. The authors have found that 
H/P, the tumour was partly encapsulated with infiltrative margins, and was composed 
of large polygonal cells with clear cytoplasm and distinct cell borders  admixed with 
smaller cells having amphophilic cytoplasm and the nuclei were large, oval to slightly 
irregular  with  coarse  chromatin.  The  neoplastic  cells  were  arranged  in  nests  and 
trabeculae, surrounded by fibrous stroma showing hyalinization. PAS stain with and 
without diastase showed intracytoplasmic glycogen in some of the tumour cells. In 
their study, IHC showed the tumour cells to be positive for CK AE1/AE3 whereas 
S-100 and vimentin were negative.
Deihimy et al in 200870 in their study of 25 cases of PA with the immuno 
markers GFAP, vimentin, MSA and S-100 found that all nonluminal cells and 
chondromyxoid areas in all PAs were positive (more than 50% tumor cells) for GFAP 
and vimentin.
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MATERIALS AND METHODS
MATERIALS
The  archival  paraffin  blocks  of  20  salivary  tumors  from a  review  of  225 
reported salivary gland entities were retrieved from the Department of Oral Pathology 
& Microbiology, Tamil Nadu Government Dental College & Hospital, Chennai 600 
003. Of these 20 cases, both classic and difficult to diagnose cases with routine and 
special sections included PA (3), PA with overlapping features (4), ACC (2), ACC 
with overlapping feature (2), ACC/SDC (1), PLGA (3), BAC (1), tumors with clear 
cells  (2)  and  unclassifiable  (2).  These  20  cases  were  subsequently  studied  with 
selective immunohistochemical markers to support or confirm the original diagnosis 
in the classic cases and the provisional microscopic diagnosis in the difficult cases. 
Streptovidin-peroxidase  technique  was  employed  to  these  cases 
immunohistochemically. To assure proper staining, salivary gland fragments, blood 
vessels and connective tissue fibers present in the sections adjacent to the tumor and 
within the tumor were used as internal positive controls. The antibodies used in the 
study as well as specific protocol information are listed in the Table 1.
METHODS
HEMATOXYLIN AND EOSIN STAINING PROCEDURE:  71  
1. Sections were deparaffinised with xylene.
2. Hydrated with descending grades of alcohol.
3. The sections were drained and transferred to hematoxylin, where they were left 
    for 10 minutes.
4. The slides were then drained and washed in running water until the sections were 
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     blue.
5. The sections were dipped in acid alcohol where they were agitated for a few    
     seconds and again washed in running water until blue again.
6. The sections were counterstained with Eosin for 30 seconds.
7.  The sections were washed in running water for 3-4 minutes, to differentiate the 
     Eosin.
8.  After draining, the sections were dehydrated in ascending grades of alcohol.
9.  The sections were cleared with xylol, where they were given two changes for 30 
      seconds each..
10. The sections being clear, the slides were dried and mounted with DPX (Distrene
      80 Dibutyl phthalate Xylol ) under a cover slip.
Results
1. Nuclei:        Blue.
2. Cytoplasm: Varying shades of pink. 
Special  stains  like  mucicaramine,  PAS,  PAS-D, PTAH were employed for 
selected cases.
MATERIALS  USED  FOR  IMMUNOHISTOCHEMISTRY  STAINING 
PROCEDURE:
1. Primary antibodies:
      i)     Anti actin antibody (1A4)
ii)    Anti vimentin antibody (V9)
iii)   GFAP antibody (GA-5)
iv)  Anti CD 117 (C-KIT) antibody
v)   Anti cytokeratin antiboby. (AE1/AE3) 
vi)  S100 (few cases)
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2.  Secondary  antibody  kit:  (Super  SensitiveTM Polymer-HRP  IHC  Detection 
System)
i)     BioGenex peroxidase block
ii)    BioGenex super enhancer
iii)   BioGenex polymer-HRP complex 
iv)   BioGenex power block
       v)   BioGenex DAB chromogen 
       vi)  BioGenex DAB substrate buffer 
3. Counterstaining reagent:
      i)     Harri’s hematoxylin
4. Dehydrating agent:
             Graded alcohol (100%, 95%, 90%, 70% and 50%)
5. Wash buffers:
      i)     Tris buffered saline (TBS) (pH-7.6) – 0.30 gms of Tris buffer mixed with 4 
             gms of Nacl.
     ii)     Distilled water
6. Xylene
7. Antigen retrieval solution
             Citrate buffer (pH-6) – 500 ml of distilled water mixed with 1.05gms of citric 
              acid salt.
 8.  Pap pen
 9.  Mixing vial
10. Pressure cooker
11. PH analyse meter.
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MATERIALS  USED  FOR  HEMATOXYLIN  AND  EOSIN  STAINING 
PROCEDURE:
1.   Clearing agent: 
             Xylene
2.   Dehydrating agent:
             Graded alcohol (100%, 90%, 70% and 30%)
3.   Hematoxylin
4.   Eosin
5.   Mounting agent:
             DPX (Distrene 80 Dibutyl phthalate Xylene)
6.   Cover slip.
IMMUNOHISTOCHEMISTRY STAINING PROCEDURE  72  
1. SECTIONING:
       Tissue sections of 3 micron thickness were made in leica semi-automated (Rm 
    2245) microtome and taken onto the gelatin coated slides.
2. DEPARAFFINISATION:
    The sections were deparaffinized by immersing the slides  in xylene for 2 
changes.
3. REHYDRATION:
    The sections were rehydrated by taking them through 2 changes of alcohol. 
Then the slides were kept immersed in distilled water for 30 seconds.
4. ANTIGEN RETRIEVAL:
          Antigen  retrieval  was  done  by using  standard  pressure  cooker  method 
containing boiling citrate buffer solution for 5 minutes.
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5. IHC STAINING PROCEDURE:
          All the reagents stored in refrigerator were brought into room temperature 
(24-28 degree Celsius) prior to immunostaining. At no time, the tissue sections were 
allowed to dry during the staining procedure.
 Step 1: Blocking of peroxidase activity
          After tapping off the excess buffer from the slides, the sections were covered 
with 3% hydrogen peroxide block for 15 minutes following which slides were gently 
washed with Tris buffer (TBS) and kept for 5 minutes in the same solution.
Step 2: Power block
          Sections were treated with power block for 10 minutes. After the power block, 
   slides were not treated with Tris buffer.
  Step 3: Primary antibody application
          The excess buffer was tapped off and the sections were covered with optimally  
   diluted primary antibody. The slides were incubated for 1 hour with CK, SMA and 
   GFAP and 1½  hour with vimentin and half-an hour for S100. Then slides were 
washed gently with TBS and kept in TBS bath for 5 minutes.
Step 4: Link (secondary antibody application)
         After tapping off excess buffer, the sections were incubated with link antibody 
for 45 minutes and then rinsed gently with TBS and kept in TBS bath for 5 minutes. 
Step 5: Streptavidin peroxidase application
         The excess buffer was tapped off and the sections were incubated in streptavidin 
peroxidase for 30 minutes. Then slides were washed gently and kept in TBS bath for 5 
minutes.
Step 6: Substrate chromogen application
        The tissue sections were completely coated with freshly prepared substrate 
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   chromogen solution using pasteur pipette for 5-10 minutes (or) until acceptable 
colour  intensity  has  reached.  The  slides  were  then  washed  with  TBS  and 
counterstained.
 Step 7: Counterstaining
        The sections were immersed in Harri’s hematoxylin for 10 minutes and then 
washed gently under running water and allowed to dry. 
Step 8: Mounting
        The sections were dehydrated, cleaned in xylene and then mounted using DPX.
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OBSERVATIONS & RESULTS
PATHOLOGIC FINDINGS
PLEOMORPHIC ADENOMA
A total of 7 PAs was included in this study, out of which, 3 were classic cases 
and 3 had resemblance to ACC and the other resembled PLGA. Histopathological 
features of theses cases were as follows:
Classic case 1, showed clear oncocytic cells with oval nuclei as well as few 
cells with eosinophilic granular cytoplasm and also displayed focal areas of stellate 
shaped cells in a myxoid stroma. There was no capsule and the tumor mass was under 
the cover of overlying epithelium.
Classic case 2,  showed a well  encapsulated tumour with foci of chondroid 
areas, double layered ductal structures with clear cells in the outer layer, adipocytes 
and  squamous  metaplasia  with  keratin  pearl  were  also  noted.  Uninvolved  normal 
minor salivary tissue was found at the edge of the lesion.
 Classic case 3, showed sheets of plamacytoid cells, glandular epithelial cells 
and hyaline globules. The lesion was well circumscribed by fibrous capsule.
PA that resembled PLGA, showed partially circumscribed lesion consisting of 
isomorphic  cells  with  washed  out  nuclei  arranged  in  sheets  and  ductular 
configuration. Papillary projections into the cystically dilated ducts were also found. 
Admixture of adipose tissue was also evident. 
PA that resembled ACC, showed cribriform areas and tubular growth patterns 
with dark staining angular cells and the stroma ranged from myxoid to hyaline.
PLGA
PLGA comprised 3 cases in this study. In general, all the PLGAs exhibited 
diverse morphologic growth patterns. Two PLGA showed solid lobular or organoid 
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growth pattern,  cystic and fascicular growth patterns. The peripheral  cells  in solid 
lobular growth pattern showed palisading. The cells were either isomorphic, pale oval 
shaped  nuclei  with  washed  out  nuclei  or  large,  eosinophilic  cells  with  granular 
cytoplasm.  Areas  of  clear,  squamous  and mucous cells  were also  seen  strikingly. 
Spindle  cells  comprised  the  fascicular  growth  pattern.  The  solid  lobular  growth 
pattern was surrounded by PAS positive hyaline material. The stroma of these tumors 
varied from fibrous to focal myxoid areas or fibrous to hyalinized areas. Both were 
partially encapsulated. The third PLGA showed tumors cells arranged as solid islands 
with cribriform spaces, and solid nests arranged in an organoid growth pattern. The 
individual cells were isomorphic and showed pale staining nuclei.
ACC  /SDC  
ACC comprised  of  a  total  of  4  cases.  The first  case of  ACC showed two 
component: an ACC component and BA component. The ACC component showed 
hyperchromatic cells arranged in a cribriform growth pattern. In the BA component, 
solid, trabecular and tubulo-ductular growth pattern with interconnecting strands were 
noted. The individual cells appeared basaloid and columnar in shape. The solid island 
showed squamous  eddies.  The  stroma in  this  field  was  more  vascular.  Both  foci 
merged with each other imperceptibly.
The second case of ACC showed an ACC component and CA component; the 
ACC foci showed cribriform and tubular growth pattern. The tubules were lined by an 
inner layer of darker staining cells and outer clear cells.  In the centre of the field, the 
CA foci showed interconnecting strands of double layer of epithelial cells supported 
by vascular stroma. The lesion was encapsulated but showed capsular infiltration by 
the ACC component.
Third  case  of  ACC was  entirely  comprised  of  solid  islands  with  small, 
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hyperchromatic, angular cells with inconspicuous cytoplasm.The tumor islands were 
surrounded by retraction spaces in some islands. No other growth pattern was evident 
in the section.
The  fourth  case  of  ACC  exhibited  nodules  of  tumor  cells  arranged  in 
cribriform  and  tubular  growth  patterns.  The  individual  tumor  islands  were 
hypocellular and contained abundant hyalinized tissue organized into small globules 
or  spherules.  The  hyaline  material  was  surrounded by hyperchromatic,  angular  to 
ovoid cells. Basophilic mucin predominated in cribriform and ductular spaces.  The 
cribriform nests contained cells with round to oval hyperchromatic nuclei with scant 
cytoplasm and in some cribriform islands, cells with pale nuclei surrounding vascular 
spaces were noted. At the periphery of the tumor, perineural and perivascular invasion 
as well as infiltration into the minor salivary gland was noted.
SDC
Histologically, the tumor consists of solid and pseudo cribriform nests. Many 
of the nests showed central comedonecrosis and tumour islands were surrounded by 
dense  fibrous  tissue.  Neoplastic  cells  were  cuboidal  to  polygonal  with  moderate 
amount of cytoplasm and showed higher grade of nuclear cytology.
BAC
It was composed of uniform, densely packed small basaloid cells and large 
polygonal cells forming solid lobules, sheets, islands or nests. The periphery of the 
tumor  nests  was  lined  by  a  row  of  palisading  hyperchromatic  cells.  Some  nests 
showed foci of hyalinized material within the tumor islands. In most islands a PAS 
positive hyaline material was found. The overlying epithelium was ulcerated and the 
tumor cells showed infiltration into the minor salivary glands.
UNUSUAL ADENOCARCINOMA:
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Two cases of adenocarcinoma defied categorization. On of the case showed 
multiple  growth  patterns  that  include  solid  islands,  cribriform,  tubular,  cystic, 
trabecular and trabeculo-tubular growth patterns. The cribriform and ductular spaces 
contained basophilic  to eosinophilic  material.  In some areas,  the tumor cells  were 
arranged  into  interconnecting  strands  with  luminal  columnar  and  basal  cells.  In 
general, the cells were isomorphic but the tumor islands with or without cribriform 
spaces showed high grade nuclear cytology, especially at the periphery. The stroma 
ranged from fibrous to myxoid in nature. Perineural invasion was also observed. 
The  other  adenocarcinoma  showed  features  consistent  with  CA  and 
PLGA/ACC. CA foci displayed double layered columnar to cuboidal cells arranged in 
canalicular pattern. The stroma was fibrillar to vascular. Solid interconnecting islands 
with lumina were also evident. In other fields,  solid islands and trabecular-tubular 
pattern reminiscent  of  BA was also noted.  Foci  of  cribriform and tubular  growth 
pattern resembled PLGA or ACC. Infiltration into bone was also noted.
CLEAR CELL SALIVARY GLAND TUMORS
Two cases of clear cell salivary gland tumors comprised in this study showed 
clear cells arranged in an organoid nest and surrounded by fibrous to hyaline stroma. 
In one case small eosinophilic cells were also noted. One was unencapsulated and the 
other showed partial encapsulation. PAS was reactive in one case but was diastase 
labile. Both cases did not react with either mucicarmine or PTAH stain.
IMMUNOHISTOCHEMICAL FINDINGS – TABLE 1.
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PA
Classic (case 1) showed intense expression of c-kit as well as CK in the clear 
(oncocytic) cells and in the inner cells of ducts. SMA was expressed by myoepithelial 
cells and vimentin was observed in the stromal vessels. GFAP was negative. 
            Classic (case 2) showed SMA reactivity limited to stromal vessels whereas c-
kit,  GFAP and vimentin  were negative.  In  contrast  CK was weakly expressed by 
luminal cells of bilayered and single layered ducts.
Classic (case 3) exhibited intense positive reactivity to vimentin and CK in 
plasmacytoid cells. GFAP showed focal positivity of plasmacytoid cells.  In contrast 
c-kit and SMA were negative.
In the PA resembling PLGA, c-kit was strongly expressed in the luminal cells 
of ductal stuctures. Vimentin showed intense reactivity restricted to abluminal cells 
of ductular structures and showed diffuse reactivity in the stromal component. CK 
was expressed strongly in luminal cells of ductular structures, whereas SMA showed 
focal reactivity limited to abluminal cells of ductular structures. GFAP was found to 
be negative.
The  other  3  cases  of  PA  resembling  ACC,  showed  positivity  to  c-kit 
exclusively of the inner luminal cells of the duct-like structures and cribriform areas, 
whereas  SMA  positivity  was  observed  only  in  the  abluminal  cells  of  ductular 
structures. Out of these 3 cases, 2 cases were positive for vimentin, mainly in the 
abluminal cells of ductular structures and in epithelial component, while only one 
case showed focal reactivity to GFAP.  
PLGA 
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Of the 3 cases of PLGA, two PLGA with predominant oncocytic cells showed 
intense  reaction  to  c-kit,  which  showed  diffuse  cytoplasmic  reactivity  in  the 
oncocytic cells. SMA staining was limited to the stromal vessels, while vimentin was 
found in the basal part of cell membrane in one and in few scattered cells in both 
PLGA. CK was reactive  in  both  PLGA. In contrast,  in  the  other  PLGA without 
oncocytic or mucous cells, both SMA and vimentin showed similar staining pattern 
in the peripheral cells in the organoid nests, and in the peripheral cells, lining cells 
and rest of the tumor cells in the solid cribriform growth. However, staining with 
SMA  was  more  intense  than  vimentin.  CK  showed  luminal  cell  reaction  in  the 
respective growth patterns. No reaction was found with GFAP in all three PLGA.
BAC
Vimentin, CK and c-kit showed diffuse reaction in the solid islands and sheets. 
SMA expression was limited to the vessels in the stroma. GFAP was negative.
ACC
In ACC with BA component, c-kit and CK showed similar expression pattern 
in the luminal cells and squamous eddies of the solid islands in the BA foci. In the 
ACC foci the expression was noted intensely in the cribriform growth pattern. SMA 
expression was expressed found in  the abluminal  cells  in  the BA foci  and in the 
cribriform growth of the ACC foci, while vimentin and GFAP was negative in both 
foci. 
In the ACC with CA foci, c-kit, vimentin and SMA staining were negative in 
the CA foci, whereas in the cribriform growth pattern of ACC foci showed expression 
with SMA and c-kit but not to vimentin. GFAP and CK were negative in both foci.
In  the  ACC with  extensive  sclerosis,  SMA reactivity  was  observed in  the 
cribriform  and  tubular  growth  patterns.  Vimentin  staining  was  confined  to  the 
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capsule. In the larger islands with and without cribriform spaces or sclerotic areas 
were either negative or weakly reactive to SMA. CK expression was noted around the 
blood vessels within the cribriform growth pattern. Similar staining pattern was also 
noted for c-Kit. No staining reaction was obtained with GFAP staining.
In  the  solid  ACC,  tumour  cells  were  generally  unreactive  to  SMA  and 
vimentin but few cells showed reaction with vimentin. Instense staining with these 
markers were observed in the stromal connective tissue fibres. c-Kit showed diffuse 
reaction in the tumor cells of the solid islands. 
No reaction was noted with GFAP.
SDC
A negative reaction was noted in the tumor cells of SDC for all markers. The 
expression of SMA was restricted to the blood vessels and connective tissue fibers at 
the  periphery  of  the  tumour  islands.  Vimentin  showed  diffuse  expression  in  the 
stromal fibres.
UNUSUAL ADENOCARCINOMA
In the unusual adenocarcinoma, CK expression was found in the centre cells 
and vimentin at the periphery in the trabecular, trabecular-tubular growth pattern. In 
the  solid  growth  pattern  CK expression  was diffuse,  staining  both  the  centre  and 
peripheral cells. Vimentin and SMA expression in the solid islands was similar to the 
trabecular  growth  pattern.  Both  showed  expression  in  the  solid  sheets  with 
pseudolumina at the periphery and in scattered tumor cells. Expression of c-kit was 
diffuse without any recognizable pattern of expression. No reaction was obtained with 
GFAP. 
In the other unusual adenocarcinoma with features of CA and ACC/PLGA, 
S100 showed strong positivity in the luminal cells (nuclear staining) that lined the 
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canals or lumen. In the solid islands with tubules the expression of S100 was found in 
a mosaic pattern. CK showed weak reactivity in the luminal cells and no reaction was 
noted in the ACC or PLGA component. Expression of SMA was noted in a dot-like 
pattern at the periphery of cords with lumina or canals. SMA did not stain the tumor 
cells in the ACC or PLGA component. GFAP, vimentin and c-kit were found to be 
negative.
CLEAR CELL SALIVARY GLAND TUMORS
Of the two CCC, CK, c-Kit and vimentin expression was noted in the tumor 
cells (clear and eosinophilic cells) of a CCC. No staining with S100 was found and 
SMA staining was limited to the blood vessels. In the other CCC, CK showed positive 
reaction but c-Kit, S100 and vimentin did not react with the tumor cells. However, 
SMA intense staining of the stromal fibres but remain unstained in the tumor cells. 
  DISCUSSION
Salivary gland tumors comprises a heterogenous group of neoplasms and the 
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recent WHO classification list some 40 named salivary gland tumors.1 While some are 
relatively  common  tumors,  others  are  quite  uncommonly  encountered  in  routine 
practice. Tumors like PA are considered to be the most common benign salivary gland 
tumor,  and  as  such,  most  pathologists  are  well  aware  of  the  histomorphological 
spectrum of this entity. In comparison, tumors like CA are uncommon in the Indian 
context and certain malignant tumors, due to rarity and similarity,  pose diagnostic 
difficulty  in  routine  practice.  This  holds  not  only  true  for  a  subset  of  tumors 
(ACC/PLGA/BAC/SDC) but also to a wide variety of salivary gland tumors, as they 
manifest  histological  diversity  and  overlapping  features,  making  pre-operative 
diagnosis  in  routine  sections  difficult.9,  38,  55 The  literature  provides  adequate 
information  with  regard  to  the  use  of  IHC in  salivary gland tumors.2-70,  73-97 Most 
pathologists  often  employ  commercially  available  IHC  markers  to  discriminate 
potential  salivary gland tumors but  is  not  clear  whether  they provide unequivocal 
diagnostic clues in routine practice. Tumors like PA, PLGA, ACC, BAC, CCC and 
unusual tumors were assessed selectively with IHC markers to address the utility in 
the differential diagnosis. 
PLEOMORPHIC ADENOMA
PA  is  one  of  the  well  recognized  tumours  of  salivary  glands.73 It  is 
characterized  by  its  morphological  diversity  in  that  it  exhibits  both  gland-like 
epithelial and mesenchyme-like features. The epithelial component may show ductal 
proliferation in the form of intercalated ducts with lumina that are lined by a single 
layer of ductal epithelium encircled by darker staining, clear, angular myoepithelial 
cells. The cellular proliferation may take nests, solid sheets, or anastomosing cords. 
The  stroma  ranges  from  myxoid  and  chondroid  to  adipose  tissue.  The  relative 
proportions of the epithelial and mesenchymal components vary from more myxoid to 
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more cellular. The individual cellular phenotype includes plasmactyoid, polygonal or 
spindle or occasionally, oncocytic in appearance. In most cases diagnosis of PA can 
be apparent from routine sections but in certain situations it may closely resemble 
other salivary gland neoplasms that include BCA, PLGA and ACC.9, 38, 55 
IHC with SMA in PA may show positive reaction in abluminal and spindle 
cells but not in plasmacytoid, stellate or polygonal cells. The chondroid foci may also 
be negative with SMA but show positive reaction with vimentin or GFAP.4, 10, 36, 55, 70 
On the other hand, others consider that expression of vimentin can be found, with 
exception in  the luminal  and squamous cells,  in  almost  all  cells  of  PA with both 
epithelial and myoepithelial differentiation.10, 16, 55 Furuse et al,55 regard combination of 
SMA and vimentin to be more useful in identifying myoepithelial cells in PA. 
In  the  present  study  three  classic  PA  [each  predominated  by  ductal  and 
squamous  pearl  formation,  clear  cells  (oncocytic)  and  plasmacytoid  cells, 
respectively] were stained with CK, SMA, vimentin, GFAP and c-kit markers.
In  the  three  classic  PA,  c-Kit  expression  was  negative  in  two  cases  and 
expression was identified mainly in the clear cells (oncocytic cells) in the positive 
case, while GFAP was found to be positive in only one. In these classic PA, vimentin 
was found to be negative in the PA with luminal and squamous differentiation, while 
expression of SMA was focal and mostly restricted to the stromal vessels (Figure 15 E 
- H).  In the PA with clear cells (oncocytic), SMA was positive in myoepithelial cells 
but vimentin was restricted to the stromal vessels (Figure 15 D). On the other hand, 
the clear cells (oncocytic) showed intense expression with CK and c-Kit (Figure A - 
C). The c-kit expression in clear (oncocytic) cells is interesting in view of its reported 
unreactivity in  oncocytomas.26,  56 The lack of expression of SMA and vimentin is 
attributed to lack of myoepithelial differentiation in oncocytic foci.65
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Yamada et al4 & Nishimura et al10 considers that PA with luminal or squamous 
cell differentiation are less likely to react with vimentin. In the PA characterized by 
plasmacytoid cells, vimentin, GFAP and CK were positive but SMA and c-Kit was 
negative (Figure 16 A - D). The variable staining with the muscle markers indicate 
lack of  differentiation  towards  myoepithelial  phenotypes  in  two PA,3,  74 as  inbuilt 
controls within the sections showed positive reaction with these markers in the present 
study (Figure 15 F & G), while reaction with muscle markers in the more cellular PA 
correlates with the observation by others.3, 10, 16, 55,60 Interestingly, CK expression was 
also  found  in  the  plasmacytoid  cells,  which  are  considered  to  be  modified 
myoepithelial cells.22 Staining of plasmacytoid cells by CK have also been reported by 
Ogawa et al,75 According to him, plasmacytoid cells in PA are related to luminal cells 
and do not originate from myoepithelial cells, but myoepithelial markers were also 
found to be expressed in the plasmacytoid cells in the present study. This is not an 
unexpected  finding  as  myoepithelial  cells  contain  both  epithelial  and  muscle 
filaments.32, 76 
The variable IHC results with regard to GFAP in PA, where all but one was 
negative,  is  in  contrast  to  the  noted GFAP findings  in  PA.5,  23,  38,  61 In  the  GFAP 
positive cases staining was limited to the spindle and plasmacytoid cells and in the 
stroma that conforms to the reported observation for GFAP staining in PA, where 
positive reaction can be found in the myoepithelial cells or its derived stroma.5, 19, 38, 61, 
70 
PLEOMORPHIC ADENOMA WITH OVERLAPPING FEATURES
Since PLGA may show encapsulation and ductal  or tubular growth pattern 
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accompanied by myxoid or hyaline stroma, differentiation from PA is often difficult 
on routine sections. 9, 24, 73 On the other hand, cellular and cribriform areas in PA cause 
diagnostic difficulty with ACC. 
In this study, four PA showed close morphological resemblance to PLGA and 
ACC in view of the cellular and ductal features in the former (one PA), and cellular 
and  cribriform features  with regard  to  ACC (three  PA).  In  view of  this  potential 
pitfall, IHC markers like c-kit and GFAP in conjunction with SMA and vimentin was 
employed to narrow the differential.
According  to  Zarbo,77 PLGA  may  also  show  focal  reactivity  with 
myoepithelial  markers,  but is  generally said to be limited to the spindle  cells  and 
cribriform areas.28  Outer tubular and ductular structures were shown to stain with 
vimentin and SMA in both PLGA and ACC.9 In comparison, PA usually show intense 
reactivity for  muscle  markers.77  In the present  study,  although SMA and vimentin 
showed reactivity in accordance with the noted observation,10, 16, 55, 60 their expression 
was not consistently found in all this four PA. More over, expression of these markers 
remained equivocal in the area of interest, necessitating further confirmation with the 
use of c-Kit and GFAP to refine the IHC results. Expression of c-Kit was found in 
these four PA, whereas c-kit was positive in only one of the three classic PA in the 
present study. 
Interpretation of c-Kit expression in these PA assumes significance, since it is 
also reported to be expressed in PLGA and ACC.40, 44, 56, 78 In ACC expression of c-kit 
can be found in the luminal cells, in the lining cells of pseudocysts, at the periphery 
and in the proper tumor cells, 44, 56, 57, 59 while in PLGA c-kit can be seen in the luminal 
and non-luminal cells of ductular and tubular and solid lobular growth patterns but 
rarely in the lining cells of pseudocysts.59
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Although c-Kit  expression can be found in  both ACC and PLGA,44,  56 the 
luminal  cell  expression  of  c-Kit  in  these  four  PA  were  in  accordance  with  the 
observation made by others56(Figure 17 E, Figure 18 D & Figure 19 D). However, in 
view of similar expression pattern in CA and BA, caution should be exercised when 
the differential involves these neoplasms rather than PLGA and ACC.56 
GFAP was reactive in one of the PA that had resemblance to ACC but not in 
the other PA that had resemblance to PLGA (Figure 18 E). GFAP staining in PLGA 
may only be limited to the epithelial cells or negative,23, 24, 38, 61 and those cases where 
they are  positive are generally focal when compared to the focal to diffuse pattern of 
staining in PA.23  On other hand, ACC lacks GFAP reactivity. Although staining with 
GFAP helped in the differential with ACC in one PA (Figure), the pattern of c-Kit 
expression was more helpful in the differential with other ACC and PLGA in our 
study. The utility of GFAP in the differential was found to be less useful in this study 
since it was expressed in only two of the PA.9, 23 
BASAL CELL ADENOMA
BA was considered as distinct from PA because of lack of myxochondroid but 
with  hyalinized  matrix and  isocellular  features  without  myoepithelial  cell 
participation.33 However,  periductal,  epitheloid  and  spindled  (stroma-like) 
myoepithelial cells may contribute to the neoplastic proliferation in BA, indicating its 
pleomorphic cell content with regard to staining with muscle markers.33, 79 According 
to Zarbo  et  al,33 all  patterns  of  BA  show  myoepithelial  differentiation  but  most 
pronounced in the trabecular-tubular variant of BA, and as such may show positive 
reaction  with  muscle  markers.  The  pattern  of  reactivity  also  differs  in  different 
subtypes. In the tubular form the abluminal cells and in the trabecular or trabecular-
tubular forms at the tumor-interface was found to be reactive with SMA, whereas the 
62
central  cells  were  unreactive.  In  the  solid  form,  the  peripheral,  palisading  dark 
cuboidal cells have been shown to stain positively,15, 33, and in the membranous type, 
peripheral cells and cells surrounding the hyaline droplets can be stained with SMA.33
CANALICULAR ADENOMA
It is a benign salivary gland tumor found often in the minor salivary glands of 
the upper lip. It is a well circumscribed lesion that manifests a characteristic growth 
pattern with isomorphic and cuboidal to columnar cells with eosinophilic cytoplasm. 
The nuclei  are  regular,  oval  and  elongated,  and  occasionally,  the  nuclei  impart  a 
pseudostratified  appearance.  The  canalicular  growth  pattern  is  considered  to  be 
characteristic yet not diagnostic.47 It is composed of rows of columnar ductal-luminal 
cells rather than basal type cells. The cells form a double row of strands that may 
branch and then come together. Hence, the descriptive name canalicular adenoma.73 
The epithelial elements are supported by a stroma that is parvicellular, edematous and 
finely vascular. Canalicular adenoma may also show solid, trabecular and adenoid 
pattern (cribriform).73, 77 These patterns may lead to confusion with BAC, ACC, and 
PLGA especially when there is no capsule. CA characteristically show intense S100 
positivity but only focal GFAP reactivity or lack SMA and vimentin expression.9, 26, 33, 
77  Both CA and BA have also been shown to react with c-kit immunomarker.56
In the present study two cases of ACC had acceptable foci of CA and BA, 
respectively. The ACC with CA features showed double layered columnar strands 
with  vascular  stroma  and  pseudocystic  (cribriform)  spaces  enclosing  connective 
tissue. Areas of classic ACC with solid and tubular configurations were also identified 
to  warrant  a  diagnosis  of  ACC on routine  sections  (Figure  8).  The other  showed 
features more of BA than CA in an otherwise acceptable ACC (Figure 9). 
IHC results showed positive reaction with CK, SMA and c-Kit but negative 
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reaction was observed for vimentin and GFAP in the ACC with BA foci (Figure 20 A, 
B & C). Expression of CK was identified in the luminal cells and in squamous eddies 
but was negative in the ACC areas. SMA reacted with the abluminal cells in the BA 
foci and in the cribriform growth pattern in ACC areas (Figure 20 C & D). Expression 
of c-kit was identified similar to CK expression in the BA foci and was similar to 
SMA in the cribrifom growth pattern in ACC areas.  Vimentin was negative in both 
foci, while CK was negative in the ACC foci. The IHC observation in the present 
study is consistent with SMA and CK reactivity in BA,15, 46 where SMA in abluminal 
and  CK in  luminal  cells  react  positively.  The  positive  SMA reaction  pattern  and 
negative CK expression is also consistent with IHC findings in ACC.55
 In the other ACC with CA foci, SMA, vimentin and c-Kit were negative in 
the CA foci, while SMA and c-Kit but not vimentin was positive in the ACC foci. 
GFAP stained none of the foci in both cases (Figure 21). 
The c-Kit expression in both cases especially in the cribriform areas of ACC 
foci showed intense reaction (Figure 20 D & Figure 21 B), which is in contrast to 
Mino et  al,44 who observed that  c-Kit  expression  will  be  least  pronounced in  the 
cribriform growth pattern of ACC. However, Freier et al,53 have found more intense 
reaction with c-Kit in the cribriform growth pattern compared to the solid variant of 
ACC. They surmised that less intense or lack of expression in the solid variant could 
be due to loss of antigens in a more aggressive growth phenotype, and believe, that 
differences  in  clonal  evolution  of  distinct  growth patterns  in  ACC could  possibly 
account for the varied reaction among the subtypes of ACC with c-Kit. In this study 
intense reaction was not only observed in the cribriform growth pattern in these two 
ACC but also in the solid and cribriform growth patterns in all the ACC examined as 
well.
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The  literature  indicate  that  SMA and vimentin  are  generally  unreactive  in 
canalicular  adenoma  as  it  shows  only  luminal  cell  differentiation  and  lacks 
myoepithelial  participation  when  stained  with  SMA  compared  to  ACC,  which 
normally show intense staining with SMA.33,  39,  47 These results and the observation 
(variable staining in the respective foci) of the present study suggests that ACC could 
possibly originate from monomorphic adenomas as stated in the literature.20, 80 Thus, 
IHC  observation  in  the  present  study  contributed  to  the  diagnosis  of  ACC  ex 
monomorphic adenoma in these two cases.
ADENOID CYSTIC CARCINOMA
ACC is a clinically and pathologically well described entity, and occurs both 
in major and minor salivary glands, especially the palate.73 The growth patterns can be 
categorized into three types: (1) the cribriform pattern, (2) the tubular pattern and, (3) 
the solid pattern. A sclerosing variant of ACC has been emphasized in recent years 
and was considered to be histologically distinct from the three subtypes of ACC.58 
This variant typically elaborate excessive basement membrane-like material by the 
tumor cells as a measure of immuno-denfence by the tumor cells.81
In ACC, a mixture of growth patterns usually occurs within a single tumor but 
foci  of  the  cribriform  type  can  usually  be  found  even  when  one  of  the  others 
predominates.73 The cells forming these patterns have been described as isomorphic, 
in that, they are uniform in size, shape and staining qualities,73 and show both luminal 
and myoepithelial differentiation.81
A number of tumors share certain common histomorphological features with 
ACC. The tumors that may pose difficulty in separation from ACC include PA, BA, 
CA, BAC, PLGA and SDC of minor salivary gland origin, where small biopsies often 
contribute to diagnostic complexities. Nevertheless, certain characteristic histological 
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features aid in the separation of these lesions – see below. 
PA can be distinguished when it presents its diverse mesenchymal features. 
Canalicular  adenoma  show  encapsulation  and  characteristic  bilayered  columnar 
strands  associated  with  prominent  vascular  stroma.82 BA  and  BAC  may  pose 
considerable diagnostic difficulty in view of its multiple growth patterns, where solid 
islands of BAC more closely resemble ACC but show peripheral palisading. Although 
occasionally ACC show palisading, they often show cribriform structures which are 
uncommon  in  BA.73,  83 PLGA  and  SDC  may  show  solid,  tubular  and  cribriform 
growth patterns similar to ACC.73 However, the cribriform spaces in ACC are distinct 
from PLGA.84 The cribriform spaces in ACC are composed of replicated extracellular 
matrix and dual population of cells, while the spaces may contain stromal elements 
and a single cell type in PLGA.84 In SDC, the cribriform spaces are surrounded by 
cells  with higher  nuclear  cytology and comedonecrosis  in  the solid  islands.14,  63,  84 
Despite these subtle histological distinctions, accurate diagnostic interpretations arise 
when tissue specimens are inadequate, often necessitating the use of a panel of IHC 
markers to resolve the differential. Vimentin, SMA and c-Kit have been shown to be 
helpful in delineating ACC from other salivary gland tumors.40, 44, 53, 56, 57, 59 
In  this  study two tumors comprised entirely of solid  islands  permitting no 
clear cut differentiation from ACC or SDC, although each appeared to be ACC or 
SDC on routine sections.  The cells were more angular and hyperchromatic with high 
nuclear to cytoplasmic ratio and showed no comedonecrosis in ACC (Figure 10 A) 
and in  SDC, it  was  characterized by a  higher  grade  nuclear  cytology,  discernible 
eosinophilic cytoplasm and comedonecrosis (Figure 10 B & C).
IHC showed negative reaction for SMA and vimentin in the tumor cells but 
positive reaction in the stromal connective tissue - more intense with vimentin than 
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SMA, in both cases. Expression of c-kit was found in one of the two (Figure 22).
Since lack of staining with muscle markers characterizes both the solid variant 
of  ACC  and  SDC,14,  16,  26,  42,  57,  63 confirmation relied  on  the  role  of  c-kit  in  the 
distinctions. A number of studies have shown more positive correlation with c-kit 
expression in ACC than in SDC.40, 45, 56, 57, 59, 78 In contrast, only a single case of SDC 
has been shown to react with c-Kit  in an analysis  of 104 salivary gland tumors.44 
These observations indicate that  cellular  and growth features should be taken into 
consideration when interpreting IHC with c-Kit in a similar instance like the present 
study. There were subtle differences, as stated in the preceding, in the cellular and 
growth phenotypes of these two neoplasms that enabled to categorize them as ACC 
and SDC, respectively. 
In  the  cribriform growth  pattern  expression  of  vimentin  and  SMA can  be 
found in the cells lining the pseudocyst and proper tumor cells in both PLGA and 
ACC but the staining intensity or lack of staining in PLGA with SMA is considered to 
be more helpful in the differential, especially in this growth pattern.26, 57, 59   
In  the  present  study,  an  ACC  was  characterized  by  extensive  sclerosis 
resembling collagenous spherulues (Figure 10 D – F) IHC revealed SMA reactivity in 
the cribriform and tubular growth patterns but vimentin staining was limited to the 
capsule (Figure 23). In the same section, the staining intensity with SMA was weak or 
absent in the larger islands that either showed cribriform spaces or lacked (Figure  23 
E)  CK  stained  mainly  blood  vessels  within  the  cribriform  islands,  while  c-Kit 
expression was similar to CK, but it  also stained some luminal cells.   The results 
indicate  that  SMA expression  is  variable  and  CK expression  limited  to  the  cells 
around  blood vessels  than  to  the  expected  luminal  cell  reaction  in  the  cribriform 
growth pattern48 – see below.
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Sousa  et  al,39 have  stated  that  the  cribriform  spaces  represent  attempted 
luminization in a less differentiated tumor that may show positive reaction with CK, 
while inconsistent expression of CK and vimentin could possibly be linked to the 
undifferentiated nature of cells in ACC. 
Chen et al,86 proposed that the adenoid cystic carcinoma should be divided into 
two IHC groups:  a  group of  neoplastic  cells  with  prevalence  of  ductal  formation 
positive to low and high molecular weight CK’s, and the other group of neoplastic 
cells reactive with SMA and low molecular weight CK. 
The lack of CK expression, vimentin and inconsistent SMA reaction in this 
study is consistent with the above observations in ACC.
BASAL  CELL  ADENOCARCINOMA/POLYMORPHOUS  LOW-GRADE 
ADENOCARCINOMA
It  resembles basal  cell  adenoma in its  growth patterns  and lack of cellular 
pleomorphism but is defined by infiltrative features that include invasion of nerves, 
vascular  or  lymphatic  spaces,  and  occasionally,  pleomorphism.73 This  tumor  is 
characterized by growth patterns such as solid, membranous, trabecular, tubular and 
adenoid (cribriform). 
The morphologic features of BAC are well described.73 Solid growth pattern 
of BAC is characterized by uniform, densely packed basaloid cells forming variably 
sized nests. The cells in the centre of the clusters are larger and oval to elongated in 
shape  with  ill-defined  cytoplasmic  borders  and  contains  pale  nuclei,  while  the 
peripheral  cells  are  small  and  have  darkly  stained  basophilic  nuclei  with  scant 
cytoplasm  that  often  show  peripheral  palisading.  Within  the  nest  there  may  be 
squamous eddies or hyaline droplets.41, 73 In the trabecular pattern, the tumor cells are 
arranged in branching, anastomosing cords that had occasional tubular structures with 
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pseudolumina  and  areas  of  microcyst  formation.15,  82 Nuclear  palisading  will  be 
minimal in this pattern. 
 PLGA is  a  distinctive  adenocarcinoma  characterized  by  diverse 
morphological growth patterns thought to be found exclusively in the minor salivary 
glands.73, 87 PLGA is often described in most standard text books as a low-grade tumor 
characterized  by  infiltrative  growth,  morphological  diversity  and  cytological 
uniformity. The uniform cytology is often interpreted as related to the single cell type 
in PLGA. However, it refers to the low-grade malignant cytological features and not 
to the different cell types that can be found in PLGA.24 The varied growth patterns 
that  can  be  found  in  PLGA include  solid,  glandular,  cribriform (pseudoadenoid), 
ductular, tubular (usually a single layer), trabecular, lobular,  fascicular (streaming) 
and occasionally, cystic. The cell types found in PLGA are, generally, described as 
cuboidal to columnar shaped with a round to oval or spindle, vesicular to stippled or 
basophilic nuclei that may often overlap.28,  73,  87 The nuclear to cytoplasmic ratio is 
less, the cytoplasm is amphophilic to eosinophilic and the nuclei in most instances 
appear washed out. The cell borders are not distinct.24, 73,  87 The tumor cells may be 
associated with mucoid, hyaline or fibrovascular stroma.73, 87 A slate gray-blue stroma 
is regarded as characteristic of PLGA.87 PLGA may also show metaplastic changes, 
including squamous, sebaceous, and oncocytic features.87 However, the latter feature 
have not been found to be prominent in most PLGA described so far.28, 50, 87, 88 
The histological features of PLGA when present do not pose great diagnostic 
challenge,  but  in  most  instances,  because  of  the  diverse  growth  patterns  and 
histological overlap of these growth patterns with other salivary gland tumors, PLGA 
may cause considerable dilemma even to an experienced specialist pathologist.24
While PLGA have been considered to occur exclusively in the minor salivary 
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glands,  BA and BAC are generally thought to occur in major salivary glands.15,  73 
Since cases of BAC have also been reported to occur in minor salivary glands,27, 62, 89 
distinction of PLGA from BA and BAC can be quite difficult for two reasons; firstly, 
both may show solid lobular growth pattern with peripheral  palisading,  as well as 
intercellular hyaline droplets, and secondly, similar growth patterns [ductular (single 
layered), tubular and trabecular] can exist in these neoplasms.15,  28, 41, 42, 73, 87, 90 
Although PLGA can be separated from BA because of lack of encapsulation, 
the same might make it difficult to separate it from BAC. According to the literature,9, 
15, 27, 56, 62 IHC with BAC have shown to react with CK, c-Kit, SMA and vimentin. On 
the other hand, PLGA also react with these markers in addition to GFAP reactivity.16, 
23,  24,  28,  38,  61,  77,  87 Since c-kit expression can also be found in BAC, the solid lobular 
pattern seen in two PLGA of the present study may pose problems with the solid 
lobular pattern in BA, where peripheral palisading and hyaline material surrounding 
the solid islands can be seen on routine sections – see above, as also found in two of 
the PLGA in our study (Figure 11 B & C) More over, oncocytic cells and mucous 
cells are not features of BAC,15, 20, 27, 62, 73, 82, 89, 90 but found in these two PLGA. 
The pattern of SMA and vimentin expression observed in the present study 
showed that expression of SMA was limited to the blood vessels in the stroma in 
these PLGA in agreement with others,9, 24, 26, 88  while vimentin staining was limited to 
the peripheral basal part of the cell membrane in one of these two PLGA (Figure 24). 
In addition, few scattered cells within the solid lobular growth pattern also showed 
positive reaction with vimentin in both cases of PLGA.   Araujo et al,16, 88 considers 
that vimentin show reaction in PLGA, while others, 9,  26 is of the view that muscle 
markers are generally unreactive in PLGA. The observation in the present study is 
consistent  with  the  latter  proposition  that  myoepithelial  cells  are  not  the  main 
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component of these two PLGA. However, the PLGA in the Araujo et al16,  88 series 
showed reaction with vimentin in the tumor cells but not in the oncocytic cells, which 
showed  intense  reaction  with  CK  8  and  18.  Staining  with  CK  was  intense  and 
vimentin did not stain majority of cells (oncocytic and other cells) except for staining 
in the basal part of peripheral cells and in few scattered cells in the present study. 
In contrast to these two PLGA, vimentin staining was found to be diffuse but 
more intense in the peripheral cells in the solid membranous variant of BAC in the 
present study similar to the reported IHC results in BAC 9, 15, 27, 62 (Figure 25 G – J). On 
the other hand, SMA staining was limited to the blood vessels in the stroma but c-kit 
and CK expression was diffuse and less intense compared to the intense staining in 
the two PLGA cases. The CK and SMA results of the present study are in agreement 
with the IHC observation in BAC by others.62.25 GFAP was found negative in both 
PLGA and BAC in our study. 
Overall, the IHC results with regard to BAC in our study is consistent with the 
noted observations,9, 15, 25, 27, 62, 56 while the intense c-kit expression noted for the PLGA 
in  the  solid  lobular  pattern  (predominantly  oncocytic  and  mucous  cells)  is  an 
observation contrast to the negative c-Kit expression in tumors with oncocytic cells.26, 
56  In PLGA, variable (negative through moderate to positive) results were obtained 
with c-Kit by others.40, 44, 45, 56, 78 
Another PLGA, in this study, with solid islands and small nests arranged in an 
organoid pattern but without peripheral palisading showed reaction with CK, c-Kit, 
vimentin and SMA but negative for GFAP. 
The staining pattern with SMA and vimentin were more or less similar but the 
intensity of SMA and vimentin staining showed subtle differences. While both stained 
the larger solid islands characterized by cribriform spaces and pseudolumina in the 
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cells  lining these structures,  proper tumor cells  and the cells  at  the periphery,  the 
staining of vimentin was more on the basal part of the peripheral cells compared to 
the more intense membranous pattern of staining with SMA. The small nests arranged 
in an organoid pattern showed staining of the peripheral cells, while the central cells 
remained unreactive with SMA and vimentin.  Off the two markers, SMA showed 
intense reaction (Figure 25 C & D) CK showed luminal staining in both the solid 
islands and organoid nests, while c-Kit showed a mosaic pattern of staining (Figure 25 
F).
Although the solid islands with cribriform spaces and pseudolumina are not 
typical  of BAC on morphological grounds, the pattern of expression of SMA and 
vimentin may be confused with BAC, if morphological features and CK expression 
are disregarded. 
The literature indicates that staining with these markers have shown positive 
staining of the cells at the periphery more intensely than cells in the centre of the solid 
islands  with both SMA and vimentin.27 These IHC observations in  BAC are very 
similar to the observation in PLGA,  in the present study, with regard to SMA and 
vimentin staining pattern in the organoid nests but CK expression was noted only in 
the luminal cells (tubular and solid) and SMA plus vimentin stained  the solid islands 
with or without cribriform spaces similar to the observation in PLGA (Figure 25 A – 
E).11,  16,  24,  57,  59 The expression of c-Kit was found in a mosaic pattern in the solid 
islands with cribriform spaces or pseudolumina similar to the observation made by 
Epivatianos et al59 (Figure 25 F), who found c-Kit staining in PLGA in the luminal 
and non-luminal cells of ductular and tubular and solid lobular growth patterns but 
rarely in the lining cells of pseudocysts. On the other hand, expression of c-Kit in 
BAC has been reported in a membranous pattern in all forms of BAC in less than 25% 
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of  cases.56 In  the  present  study  with  regard  to  three  PLGA  and  one  BAC, 
morphological correlation with IHC confirmed the diagnosis made on routine sections 
in three PLGA and BAC in one.
UNUSUAL ADENOCARCINOMAS
Morphological diversity (growth and cellular features) is characteristic of most 
salivary gland tumors. Tumors manifesting different growth characteristics are often 
difficult to categorize into specific entity. Such tumors are at best be categorized as 
‘not otherwise specified’. At other instances, a well differentiated low-grade tumor 
may show a higher grade focus typical of other defined entities and these tumors have 
been described as de-differentiated.42, 48, 91 The most noted finding is the presence of 
SDC focus in an ACC. On the other hand, hybrid tumors consisting of two defined 
entities in a single topographical region have been described in both major and minor 
salivary gland tumors.42 The most common is PA and EMC or ACC and EMC; others 
include SDC and ACC, BAC and PLGA.
 In the present study two adenocarcinomas with overlapping features was also 
studied. One was characterized by multiple growth patterns (solid, cribriform, tubular, 
cystic,  trabecular  and  trabecular-tubular  forms)  and  the  other  primarily  showed 
features consistent with CA but had focus that could be seen in either PLGA or ACC. 
Both were difficult to classify on routine sections. They were similarly stained with 
the IHC markers used in this study; in addition, S100 was also employed. 
In the adenocarcinoma represented by multiple growth patterns, IHC showed 
CK  expression  in  the  luminal  cells  and  vimentin  in  the  abluminal  cells  in  the 
trabecular growth pattern, while CK expression was diffuse in the solid islands and 
vimentin stained the peripheral cells (Figure 26).  Similar IHC patterns have also been 
reported in the trabecular growth pattern in BAC.15, 27 Further more, the peripheral cell 
73
reaction with vimentin in the solid islands of BAC reported by Quddus et al,27 is also 
similar to our staining reaction with this marker but the pattern of CK expression is 
different from their report, where it was unreactive in the central cells in the solid 
islands. In constrast, Nagao et al,42 have observed diffuse CK reaction in the solid 
islands similar to the present study.
On the other hand, the pattern of vimentin expression in the solid sheets with 
pseudolumina would simulate the pattern of expression in PLGA,59 where vimentin 
have been shown to react with cells at the periphery, proper tumor cells and around 
the cribriform spaces (Figure 27 B, D & E). Similarly, the pattern of CK expression in 
both  luminal  and  abluminal  cells  (Figure  27  A), as  noted  here,  would  lead  to 
misinterpretation if care is not exercised to distinguish the cribriform spaces in PLGA 
from the pseudolumina commonly seen in BAC.15, 20, 27, 82 While cribriform spaces are 
characteristically seen in PLGA or ACC, they are not typical of BAC.77 The diffuse 
staining obtained with c-Kit is also consistent with BAC.56 
Taken together, the observation of morphological growth patterns and cellular 
features in conjunction with the varied IHC results for different growth patterns is 
more consistent with BAC. It may be noted that although in some fields the growth or 
cellular features were more similar to PLGA or SDC (Figure 13 D), such areas could 
possibly  represent  NOS  in  an  otherwise  BAC  or  the  phenomenon  of  de-
differentiation.48, 91  Some consider that overlapping features can occur among tumors 
that show myoepithelial differentiation and in such cases, they do not alter the basic 
diagnoses or prognostic outcomes.92
In  the  other  adenocarcinoma  with  features  of  CA  and  ACC/PLGA,  S100 
marker was utilized in addition to other markers employed in this study. The lesion 
showed S100 reaction strongly in the luminal cells that lined the canals or lumen, 
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while it showed a mosaic pattern in the rest of the tumor cells. The intense reaction 
with CK and S100 is consistent with the observation found in the literature,9, 17,  33,  77 
where it  is  stated that CA characteristically show intense S100 positivity,  but  the 
reactivity was noted most intense in the luminal columnar cells (mainly in the nuclei) 
that lined the canals or tubules, while it showed a mosaic pattern in the solid areas in 
the present study (Figure 28 B & C). This observation is opposite to the staining of 
outer cells in CA with S100 noted by others.17, 66 
Although CA have been noted to lack expression of SMA by most others,17, 26, 
33, 39, 47, 49, 77  the expression of vimentin in CA is conflicting.  17, 39, 47, 49 Ferreiro et al,17 
have found strong vimentin expression in the outer portions of the tubules or canals, 
while occasional tumor cells and stroma showed positive reaction.17, 47
In the current study, vimentin was negative whereas SMA was positive in the 
outer  portions  of  tubules  or  canals  and  stromal  fibres  in  regions  that  had  typical 
features of CA. Contrary to the present observation, Zarbo et al,33 believe that no such 
staining was possible even in the CA that had overlapping features with BCA. An 
observation they consider important in distinguishing CA with BCA features from 
BCA. It is beyond the scope of this study to explore further into the possibility of uni 
(luminal) or bicellular (luminal/myoepithelial) differentiation in CA.  However, the 
distinction is not important with regard to the biology of these entities. On the other 
hand,  both  vimentin  and SMA was negative  in  the  transformed foci  that  showed 
tubular  and cribriform growth patterns  corresponding to  PLGA or ACC foci.  The 
latter observation is diametrically opposite to the expression pattern noted with these 
markers in PLGA or ACC by others,9, 11, 13, 16,  26,  47,  55, 57, 59, 60 as well as in the present 
study – vide supra. 
Since PLGA may also show bilayered cells characteristic of CA, Furuse et 
75
al,55 regard the use of vimentin  in the differential  between CA and PLGA, where 
vimentin  strongly  stains  the  PLGA  but  not  CA.  The  lack  of  SMA  or  vimentin 
expression  in  the  adenocarcinoma  foci  (ACC/PLGA)  indicate  that  these  antigens 
might have lost during transformation. However, this observation is also in contrast to 
the observation made in the present study with regard to the ACC with CA foci, as 
noted above. 
Lack of encapsulation, as noted in the present study, was also noted by most 
others  in  CA,93,  94 and  as  such  would  lead  to  a  consideration  of  malignant 
transformation especially in view of the adenocarcinoma foci (PLGA/ACC) observed 
here. 
As to whether this lesion is nothing but a multifocal CA 73, 82, 93 or a malignant 
transformation  of  CA,  the  literature  emphasizes  the  importance  of  the  former 
possibility  than  the  later  likelihood.94 However,  the  clinical  presentation  and 
microscopic  evidence  of  invasion  of  the  adenocarcinoma  component  indicates  a 
transformation process rather than multifocality in this study.
CLEAR CELL CARCINOMA
Clear cells can be found in many salivary gland tumors that mainly include 
oncocytoma,  mucoepidermoid  carcinoma,  acinic  cell  carcinoma,  myoepithelial 
carcinoma,  and  principally,  in  epithelial-myoepithelial  carcinoma  and  clear  cell 
carcinoma.73, 95 Most or all of these neoplasms show reactivity with PAS but some are 
labile with PAS-D indicating the presence of glycogen, while acinic cell carcinoma 
show  cytoplasmic  granules  when  digested  with  diastase.  On  the  other  hand 
mucoepidermoid requires mucin stains to confirm the clear  cell  nature.  Therefore, 
diagnosis of tumors with predominant clear cells always poses diagnostic challenge in 
routine sections.43,  73,  95   Oncocytoma may show positive reaction with PTAH but in 
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some cases requires electron microscopic evaluation.73, 95 
In the present study two salivary gland tumors comprised almost or entirely of 
clear cells arranged in an organoid pattern and solid nests surrounded by dense fibrous 
tissue. One of these showed cells with eosinophilic cytoplasm but no ductal/tubular 
differentiation, bimorphic cell layers or spindle and hyaline cells were identified in 
both lesions. One was unencapsulated and the other was partially encapsulated. Both 
were stained with the special stains mentioned – see above. Negative reaction with 
mucicarmine, PTAH and lack of secretory granules with PAS-D helped to exclude 
mucoepidermoid carcinoma, oncocytom and acinic cell carcinoma. Since epithelial-
myoepithelial carcinoma may be composed of predominantly clear cells,73 IHC with 
the markers used in this study plus S100 was employed in to refine the differential.
IHC showed CK expression in both tumors, while S100 was negative. IHC 
with SMA showed reaction in both tumors mainly in the stroma (Figure 29 C & 
Figure 30 A & B). On the other hand, vimentin showed intense reaction both in the 
stroma and tumor cells (clear and eosinophilic) in one of these two but was negative 
in the other (Figure 29 A).
The  literature  revealed  that  CK,  S100  and  muscle  markers  are  generally 
positive in epithelial-myoepithelial carcinoma, indicating participation of ductal and 
myoepithelial cells in this tumor compared to luminal cell differentiation in clear cell 
carcinoma. 43,  73,  95  Therefore, this IHC pattern will be of use in the differential with 
clear cell  carcinoma and others.7,  26,  43, 96 However,  in the present study S100 was 
unreactive  in  both  tumors,  which  are  generally  intense  and  diffuse  in  epithelial-
myoepithelial carcinoma predominated by clear cells.35, 43, 73 On the other hand, muscle 
markers are reported to be negative in clear cell carcinoma,7, 31, 43, 96,  but was found in 
this study. 
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Wang et al,43 consider that clear cell carcinomas are devoid of myoepithelial 
markers. Nevertheless, some clear cell carcinomas may show positive reaction with 
muscle markers.12, 18 Felix et al,97 argues against the possibility of myoepithelial cell 
participation in CCC based on the lack of relation between the hyaline stroma seen in 
CCC  and  the  basement  membrane  type  material  elaborated  by  tumors  with 
myoepithelial cell participation. In contrast, the stroma was intensely positive to SMA 
in focal areas in the present study. Some consider that stromal reaction to SMA or 
other more specific myoepithelial markers might indicate the acquisition of smooth 
muscle phenotypes by stromal elements in salivary gland tumors.33 
The positive reaction with muscle markers but negative reaction with S100 is 
more  indicative of  clear  cell  carcinoma and excludes  the possibility of  epithelial-
myoepithelial  carcinoma,  clear  cell  myoepithelial  carcinoma,  mucoepidermoid 
carcinoma,  acinic  cell  carcinoma and oncocytoma.7,  21,  26,  67,  75,  90,  96   However,  the 
immunoprofile  of  the  present  study  should  be  carefully  evaluated  when  the 
differential  involves  renal  cell  carcinoma  in  view  of  their  positive  reaction  with 
vimentin.31 Reaction with S100 and SMA was reported to be negative in renal cell 
carcinoma.31  Additionally,  one of the two clear cell  carcinomas showed moderate 
(clear cells) to intense (eosinophilic cells) c-Kit reaction, a finding not been reported 
either for clear cell carcinoma or other primary salivary gland tumors with clear cell 
predominance. 
Although  the  present  immunoprofile  in  the  two clear  cell  carcinomas  was 
useful to exclude other clear cell salivary gland tumors, the appreciation of lack of 
pronounced atypia and dilated vessels, and clinical examination was more helpful in 
the differential with renal cell carcinoma than the reliance on the use of IHC in the 
differential. It is not clear whether c-Kit will be reactive in renal cell carcinoma, and 
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hence, their usefulness in the differential cannot be over emphasized. 
APPLICATION OF IHC IN ROUTINE PRACTICE
The  literature  provides  adequate  information  on  the  use  of  IHC  in  the 
assessment  of  salivary gland tumors,  and as  such,  shall  be  considered  to  provide 
documentary evidence for comparison. However, such studies usually involve a large 
sample, yet restricted tumor types, and the results represent the overall positive or 
negative  findings,  implicitly  conveying  an  impression  of  better  correlation  for 
diagnostic  uses.  But  for  routine  diagnostic  practice  purpose  the  use  of  IHC may 
actually  complicate  diagnostic  interpretations,  especially  when  IHC  sections  are 
reviewed by another pathologist or pathologist having limited experience regarding 
the complexities of cellular and growth patterns that may occur in a variety of salivary 
gland tumors. For example, a focal area of positive reaction at the edge of the section 
may result from edge effect and when this is overlooked may lead to false positive 
interpretations.  Similarly,  when  a  given  marker  stains  only  the  cells  at  the 
tumor/stroma interface and cells in the stroma rather than the majority of tumor cells 
would likely be construed as negative with that particular maker(s). This was evident 
in some of the PLGA in this study where the staining intensity with a certain maker 
was found to be variable, that ranged from less intense to focal or intense staining 
depending upon the cellular composition and growth patterns. When an unexpected 
result occurs, as found in the two PLGA with oncocytic cells and in the clear cell 
carcinoma, the final interpretations may be complicated when the growth patterns and 
cellular heterogeneity are not taken into consideration. The same inference can also be 
drawn for unusual tumors (in this study) if the pattern and intensity of IHC reactivity 
in the whole section are overlooked. Tumors showing features of two defined entities 
may lead to errors in interpretation when the secondary focus are not recognized as 
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minor  component or  given  more  importance.  In  such  situations,  it  should  be 
categorized  based  on  the  predominant  morphogenetic  growth  features  rather  than 
based on the IHC outcome. On occasion the field of interest may not be found in the 
IHC sections either due to technical deficiency in the IHC procedure or due to loss of 
tissue material in the block. In such situations it is difficult or impossible to determine 
the  specific  diagnosis  for  what  IHC  was  actually  intended.  Such  difficulty 
encountered in the present study necessitated re-staining in few instances but this will 
add to the financial burden for the patients in routine practice. Nevertheless, IHC may 
serve as a useful tool if all these potential pitfalls are kept in mind and when the IHC 
interpretations are made in conjunction with a reference H & E section.
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SUMMARY
About  20  salivary  tumors  were  retrieved  from  a  review  of  225  reported 
salivary gland entities from the Department of Oral Pathology & Microbiology, Tamil 
Nadu Government Dental College & Hospital, Chennai 600 003. Of these 20 cases, 
both classic and difficult to diagnose cases with routine and special sections included 
PA (3), PA with overlapping features (4), ACC (2), ACC with overlapping feature 
(2), ACC/SDC (1), PLGA (3), BAC (1), tumors with clear cells (2) and unclassifiable 
(2). These 20 cases were subsequently studied with selective immunohistochemical 
markers  to  support  or  confirm the  original  diagnosis  in  the  classic  cases  and the 
provisional  microscopic  diagnosis  in  the  difficult  cases.  Streptovidin-peroxidase 
technique was employed to these cases immunohistochemically.
The results of the present study showed that PAs exhibited positivity to CK in 
100% of cases, vimentin in 71% of cases, SMA in 57% of cases and c-kit in 71% of 
cases. PLGAs were positive to CK, vimentin and c-kit in 100% of cases and to SMA 
in 50% of cases. ACCs showed positivity to CK in 50% of cases, vimentin in 25% of 
cases, SMA in 75% of cases and c-kit in 100% of cases. GFAP staining was negative 
in all ACCs, PLGAs and 70% of PAs. BAC exhibited reactivity to all markers except 
GFAP,  whereas  SDC  was  negative  to  all  markers  (CK,  c-Kit,  GFAP,  SMA   & 
Vimentin). CCC demonstrated positivity in 100% of cases to CK and SMA (stroma 
only) and in 50% of cases to vimentin, while c-kit and S-100 was negative. Unusual 
adenocarcinomas  were  positive  to  CK  and  negative  to  GFAP  in  100% of  cases, 
whereas 50% of cases were positive in vimentin,  c-kit  and SMA. Out  of the two 
unusual adenocarcinomas S-100 was used in only one case, where it was positive. Of 
the markers used in this study, SMA, vimentin and c-Kit have been found most useful 
in the differential of PA, PLGA, BAC, and ACC. Further, the pattern of reaction with 
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these markers both between different tumor entities and within an individual growth 
pattern of a tumor was found to be more useful than the outcome of quantitative or 
qualitative staining.
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CONCLUSION
The use of IHC as a supplemental diagnostic tool in border line or difficult 
salivary gland tumors may well augment the routine microscopic differential as found 
in this study for most cases. However, caution should be exercised when interpreting 
the IHC results because of similar but not identical results observed for certain tumors 
and in certain fields of the same section in a given tumor for a given marker. The 
latter observation is important when interpreting IHC sections of a tumor with NOS or 
transformed foci. Therefore, it is observed that reliance on the positive or negative 
IHC results without actually observing the pattern of reactivity or lack of it may likely 
lead to inappropriate diagnosis, especially when growth patterns and cellular features 
are overlooked or not interpreted in conjunction with H & E slides. Additionally, the 
cost and time factor should be considered before advocating IHC for tumors that do 
not require different therapeutic measures.
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